The QualityStocks Daily Monday, February 12th, 2024

Today's Top 3 Investment Newsletters

360 Wall Street(BMR) $9.9500 +371.56%

QualityStocks(RNLX) $1.2500 +228.00%

MarketClub Analysis(MGIH) $3.1100 +201.94%

The QualityStocks Daily Stock List

Renalytix PLC (RNLX)

StockEarnings, MarketBeat, TradersPro, Zacks, StocksEarning, FreeRealTime, Trades Of The Day, QualityStocks, MarketClub Analysis, Daily Trade Alert and BUYINS.NET reported earlier on Renalytix PLC (RNLX), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Renalytix PLC (NASDAQ: RNLX) (OTC: RTNXF) (LON: RENX) (FRA: 209) is an AI-enabled in vitro diagnostic firm that is focused on finding solutions for kidney ailments.

The firm has its headquarters in New York, the United States and was incorporated in 2018, on March 15th by James McCullough. Prior to its name change in June 2021, the firm was known as Renalytix AI Plc. It operates as part of the diagnostics and research industry, under the healthcare sector. The firm serves consumers around the globe.

The company is focused on optimizing the clinical management of kidney disease. It is party to license agreements with Joslin Diabetes Center Inc., which entails the development and commercialization of products for the diagnosis and prediction of kidney disease using biomarkers; Mount Sinai Health System for the development of products for kidney disease diagnosis; and Kantaro Biosciences LLC, for the development and commercialization of lab tests to detect antibodies against SARS-CoV-2. The company is also party to a partnership agreement with Wake Forest School of Medicine, Wake Forest Baptist Health and Atrium Health, which involve the implementation of a clinical care model to decrease the progression of kidney disease, improve kidney health and reduce kidney failure in high-risk individuals.

The enterprise’s offerings include a diagnostic platform known as KidneyIntelX, which uses an AI-enabled algorithm to generate a unique patient score for the diagnosis and prognosis of kidney disease.

The company’s KidneyIntelX product was recently granted breakthrough designation by the FDA. The firm remains focused on advancing value-based care which will help create shareholder value while benefiting patients with kidney diseases.

Renalytix PLC (RNLX), closed Monday's trading session at $1.25, up 227.9979%, on 52,155,108 volume. The average volume for the last 3 months is 368,413 and the stock's 52-week low/high is $0.2449/$4.0377.

T2 Biosystems (TTOO)

MarketBeat, QualityStocks, StockMarketWatch, Schaeffer's, MarketClub Analysis,, BUYINS.NET, InvestorPlace, StreetInsider, TopPennyStockMovers, Barchart, TradersPro, TraderPower, Stock Gumshoe, Daily Trade Alert, ProTrading Research, The Stock Dork, The Street, Trades Of The Day, StockEarnings, Buzz Stocks, Investing Daily, Investing Futures, InvestorsUnderground, bullseyeoptiontrading, OTCtipReporter, Penny Pick Finders, PennyStockProphet, PennyStockScholar, Profitable Trader Authority, Wealth Insider Alert, StockOnion, Street Insider, The Online Investor, Trading Concepts and PoliticsAndMyPortfolio reported earlier on T2 Biosystems (TTOO), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

T2 Biosystems Inc. (NASDAQ: TTOO) (FRA: 3T2) is an in vitro diagnostics firm that is focused on the development of product candidates and diagnostic products internationally as well as in the United States.

T2 Biosystems Inc. operates in the U.S. and was established on April 27, 2006 by Ralph Weissleder, W. David Lee, Lee Josephson, Tyler Jacks, Robert S. Langer Jr. and Michael J. Cima. The firm has its headquarters in Lexington, Massachusetts. The company has collaboration agreements with Allergan Sales LLC and Canon U.S. Life Sciences Inc. to develop a detection diagnostic test panel to identify Lyme disease and other pathogen species.

T2 Biosystems Inc. is part of the medical equipment and supplies manufacturing industry and provides diagnostic instruments, like the T2 Magnetic Resonance technology for the detection of pathogens, biomarkers and other abnormalities in unpurified sample types from patients (the samples include urine, cerebral spinal fluid, sputum, saliva, serum, plasma and whole blood).

T2 Biosystems Inc.’s products include an instrument used to detect pathogens that are linked to Lyme disease and sepsis dubbed the T2Dx Instrument; a penal that is used to identify Candida species from whole blood that is known to cause sepsis, called T2Candida Panel and a multiplex diagnostic panel that can detect different bacterial pathogens linked to sepsis dubbed T2Bacteroa Panel. In addition to this, the firm also provides a coronavirus molecular diagnostic test called T2SARS-CoV-2 Panel and a panel used for the sensitive and early detection of carbapenemase-resistance markers called the T2Resistance Panel.

T2 Biosystems Inc. announced recently that its T2SARS-CoV-2 Panel can detect different covid-19 strains including the Brazil, South Africa and UK variants. With the pandemic still plaguing most regions in the world, the tool will be highly reliable and useful for many healthcare systems.

T2 Biosystems (TTOO), closed Monday's trading session at $6.49, up 32.7198%, on 5,290,053 volume. The average volume for the last 3 months is 446,324 and the stock's 52-week low/high is $3.36/$142.00.

BIGG Digital Assets (BBKCF)

TradersPro, InvestorPlace, QualityStocks and MarketBeat reported earlier on BIGG Digital Assets (BBKCF), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

BIGG Digital Assets Inc. (OTCQX: BBKCF) (CNSX: BIGG) (FRA: 7111) is a holding firm involved in the digital assets and blockchain technology industry.

The firm has its headquarters in Vancouver, Canada and was incorporated in 2014, on October 17th by Marty Anstey, Anthony Zelen, Lance Morginn and Shone Anstey. Prior to its name change in September 2019, the firm was known as Big Blockchain Intelligence Group Inc. The firm serves consumers in the e-commerce and financial sectors across the globe.

The company operates through the digital currency sales and blockchain technology development business segments. It is party to a partnership with Blockchain Foundry Inc., which entails the development of a risk scoring and forensic product for syscoin-based tokens. The company also provides exchange and brokerage software which makes the sale and purchase of cryptocurrency easily accessible to the investor and mass consumer, with a focus on safety and compliance.

The enterprise develops and provides cryptocurrency and blockchain search, data analytics and risk-scoring tools and investigation services. It offers a blockchain analytics and agnostic search engine dubbed Qlue, which allows law enforcement, government agencies, regulators and regulatory technology to visually monitor, track and trace cryptocurrency transactions at the forensic level. It also provides a risk score for Bitcoin wallets, dubbed BitRank Verified, which allows regulatory technology, retailers, exchanges, automated teller machines and banks to meet their compliance/regulatory requirements.

The company recently reported its latest financial results which show growth in its revenues. It is focused on executing its core business plans which center on partnership expansions, product enhancements, customer acquisition and continued growth.

BIGG Digital Assets (BBKCF), closed Monday's trading session at $0.2584, up 26.2335%, on 1,581,085 volume. The average volume for the last 3 months is 104,545 and the stock's 52-week low/high is $0.0962/$0.345.

GSE Systems, Inc. (GVP)

SmarTrend Newsletters, Wall Street Resources, StockMarketWatch, StreetInsider, QualityStocks, StockOodles, PennyOmega, MarketBeat, SmallCapVoice, BestOtc, CRWEFinance, CRWEPicks, CRWEWallStreet, DrStockPick,, PennyToBuck, StockHotTips, StreetAuthority Daily, MicroCap Gems, Barchart, Wealth Daily, Zacks, Stock Spike, Timothy Sykes and The Street reported earlier on GSE Systems, Inc. (GVP), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

GSE Systems, Inc. (NASDAQ: GVP) (FRA: GSE) is focused on the provision of staffing services, technical and professional engineering and simulation software to the process and power industries in various countries around the globe.

The firm has its headquarters in Columbia, Maryland and was incorporated in 1994, on March 30th. It is party to a strategic collaboration with ABB Bailey Japan Ltd which entails the provision of process simulation solutions for its Nikonkai LNG terminal in Niigata, Japan. The firm serves consumers across the globe, with a primary focus on Europe, Asia and the United States.

The company operates through the nuclear industry training and consulting, and the performance improvement solutions segments. The former segment provides project managers, technical engineers, procedure writers, planners, nuclear operations instructors, work management specialists training materials developed for the nuclear power industry. On the other hand, the latter segment is engaged in the provision of engineering services and operation training systems for the fossil fuel and nuclear power generation and process industries, as well as simulation products, which include interactive computer-based tutorials/simulations, power plant thermal performance optimization and power plant high-fidelity simulation solutions.

The enterprise markets its services and products through strategic alliance partners, representatives and agents and its network of direct sales staff. Its products are used in the metals, power generation, pharmaceutical, petroleum refining, food and beverage and specialty chemical industries.

The firm was recently awarded a contract to deliver a web-based thermal system monitoring program by a huge U.S. nuclear power plant operator. This contract will not only bring in additional revenue into the firm but may also help extend its consumer reach, which will be good for investments.

GSE Systems, Inc. (GVP), closed Monday's trading session at $1.89, up 24.3421%, on 256,400 volume. The average volume for the last 3 months is 202,118 and the stock's 52-week low/high is $1.21/$11.30.

Jones Soda (JSDA)

QualityStocks, SmarTrend Newsletters, MicrocapVoice, OTCPicks, Greenbackers, CoolPennyStocks, HotOTC, Hit and Run Candle Sticks, Stock Rich, BullRally, Penny Invest, StockEgg, Stockpalooza, Stock Traders Chat, SmallCapVoice, OTCReporter, PennyTrader Publisher, Bull Warrior Stocks, Stock Analyzer, SuperNova Elite, Hidden Stocks, TopPennyStockMovers, FNNO Newsletters, Dividend Opportunities, TopStockAnalysts,, TradersPro, Bull in Advantage, BestOtc, AllPennyStocks, CRWEPicks, Market Wrap Daily, StockHotTips, Momentum Traders, NanoCap Gems, Actual Gains, Wealthpire Inc., PennyOmega,, PoliticsAndMyPortfolio, PricelessPennyStocks, Stock Fortune Teller and Investor Update reported earlier on Jones Soda (JSDA), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Jones Soda Co. (OTCQB: JSDA) is focused on the development, production, marketing and distribution of beverages.

The firm has its headquarters in Seattle, Washington and was incorporated in 1986 by Peter M. van Stolk. It operates as part of the non-alcoholic beverages industry, under the consumer defensive sector. The firm serves consumers around the globe, with a focus on the United States and Canada.

The enterprise offers a premium non-carbonated beverage known as Lemoncocco; and a premium carbonated soft drink known as Jones soda. It also provides private label and co-branded products. The enterprise also provides fountain products, which include sugar free cola and cane sugar cola, lemon lime, root beer, orange and cream and sweetened cane sugar ginger ale. This is in addition to selling a number of products online, such as customized label sodas, candy and wearables, among other products. It licenses its trademarks to be used on products sold by various manufacturers. The enterprise distributes and sells its products via regional and national retail accounts, and a network of independent distributors, as well as via sandwich shops, delicatessens, restaurants, gas stores, convenience stores and grocery stores. It operates more than 200 Meijer stores in 6 states in the Midwest.

The company recently ventured into the cannabis space after it launched THC-infused sodas, gummies and syrups. This move not only positions it for significant growth in this burgeoning industry but will also bring in additional revenue into the company, help it extend its consumer reach and positively influence investments into the company.

Jones Soda (JSDA), closed Monday's trading session at $0.215, up 24.8983%, on 762,824 volume. The average volume for the last 3 months is 25,752 and the stock's 52-week low/high is $0.117965/$0.2748.

Sage Potash (SGPTF)

We reported earlier on Sage Potash (SGPTF), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Sage Potash Corp. (OTC: SGPTF) (CVE: SAGE) is a mineral exploration firm that is focused on acquiring, exploring for and developing potash properties.

The firm has its headquarters in Vancouver, Canada and was incorporated in 2021. It operates as part of the natural resources sector. The firm serves consumers around the globe, with a focus on those in the United States.

The company has a large portfolio of mineral rights in the prolific Paradox Basin in Southeastern Utah, USA. It is dedicated to providing a local potash supply to American farmers to ensure access to a reliable source free from supply chain disruptions and global politics that can threaten food supply and prices.

The enterprise holds a mineral lease located in the State of Utah which comprise of its Sage Plain Potash property. This property is located roughly 65 miles south of the Cane Creek mine and in the heart of the Paradox Basin. The property is situated in southeastern Utah in San Juan County, near the Utah/Colorado border. The property encompasses approximately 6,538 acres (2,282 hectares) of Utah State Potash Mineral leases, plus additional lands under private lease. In addition to this, the enterprise is focused on exploring additional potential revenue sources known to occur within the Paradox Basin via its Sage Lithium Corp. The primary objective of Sage Lithium is to conduct testing for lithium and other soluble saline minerals within the existing brine hosting strata covered by Sage Potash’s private mineral lease portfolio.

The firm, which recently received approvals for exploration at its Sage Plain potash project, remains focused on advancing exploration efforts at its properties and generating additional value for its shareholders.

Sage Potash (SGPTF), closed Monday's trading session at $0.0762, off by 0.131062%, on 20,000 volume. The average volume for the last 3 months is 532,447 and the stock's 52-week low/high is $N/A/$N/A.

ElectraMeccanica Vehicles Corp. Ltd. (SOLO)

Green Car Stocks, InvestorPlace, QualityStocks, StocksEarning, Kiplinger Today, Schaeffer's, MarketClub Analysis, StockMarketWatch, TradersPro, GreenCarStocks, StockEarnings, BUYINS.NET, Trades Of The Day, MarketBeat, The Street, TopPennyStockMovers, Zacks, Daily Trade Alert, The Online Investor, Small Cap Firm, SmallCapVoice, VectorVest, Eagle Financial Publications, Cabot Wealth and PoliticsAndMyPortfolio reported earlier on ElectraMeccanica Vehicles Corp. Ltd. (SOLO), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

The Chinese government has promised to support the expansion of domestic carmakers into international markets amid a flurry of trade sanctions against electric vehicles from China. The country’s Ministry of Commerce recently posted a document outlining 18 guidelines for China’s central bank and several departments to boost new energy vehicle trade (NEV).

China’s commerce ministry will partner with nine local departments and institutions to undertake activities such as easing Chinese export processes, boosting yuan settlements overseas and encouraging domestic carmakers to build auto R&D centers in foreign nations. The guidelines also push for Chinese carmakers to work with foreign researchers to figure out efficient means of using “global innovation resources.” China’s Ministry of Commerce is calling for local NEV makers to partner with overseas companies to bolster their overseas supply chains for both electric vehicles and electric vehicle batteries.

Additionally, the ministry instructed customs and transport departments to limit processing times to improve logistics, boost transportation safety and help EV makers grow their shipping fleets. The new guidelines also called on the government to boost credit mechanisms for new energy vehicle companies through higher export credit insurance issuances and easing cross-border yuan settlements.

Most of the guidelines outlined in the document dealt with the increasing risk of trade restrictions against Chinese-made electric cars in foreign markets. Several Chinese companies have already expanded outside the nation’s borders and have attracted plenty of consumer attention due to their low-cost offerings. However, regulators in foreign markets have turned their eyes to cheap EV exports from China. Last year, European Union leaders launched a probe into the cheap Chinese cars streaming into the EU market and claimed that the Chinese government may be using millions of dollars in subsidies to artificially lower EV prices.

Europe is the second largest EV market on the globe after China, and the continent is a large market for electric cars made in China. With massive government subsidies lowering their production costs, Chinese EV makers can price their EVs at significantly lower points.  This has resulted in cheap EVs from China flooding into the EU market. EU lawmakers say these “artificially cheap” electric cars threaten to price European carmakers such as Volkswagen out of the market.

The United States is also looking to increase tariffs on Chinese electric cars and other products amid an escalating trade war between the two nations. U.S. Commerce Secretary Gina Raimondo recently said electric cars from China are a national security threat.

With China determined to bring the competition to international actors such as ElectraMeccanica Vehicles Corp. Ltd. (NASDAQ: SOLO), only the companies with EVs that are reliable, affordable and appeal to customers will survive.

ElectraMeccanica Vehicles Corp. Ltd. (SOLO), closed Monday's trading session at $0.268, up 3.9566%, on 384,654 volume. The average volume for the last 3 months is 378,240 and the stock's 52-week low/high is $0.2111/$1.04.

TerrAscend Corp. (TSNDF)

QualityStocks, InvestorPlace and Cabot Wealth reported earlier on TerrAscend Corp. (TSNDF), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Last month, Israel’s Ministry of Health implemented rules that would make it easier for physicians to administer medical marijuana to their patients. In a statement, the ministry explained that these changes would improve availability of marijuana, decrease bureaucracy for patients who needed the drug and increase medical autonomy of the physicians.

The ministry also noted that emphasis was being placed on affording physicians more discretion to administer medical marijuana in their areas of expertise for a range of indications.

Bazelet Group’s Head of business development, Itai Rogel, stated in an email that prior to this change in policy, marijuana was given to patients as a last resort. This, of course, excluded patients in palliative care and those undergoing oncology treatment. He added that these changes mean that marijuana treatment is here to stay and is becoming more accepted as an additional, alternative mode of therapy. Bazelet Group is involved in the production of a large quantity and wide variety of medical marijuana products.

It is expected that more changes will be announced next month, including the following:

  • permitting marijuana to be prescribed by specialist physicians working at public hospitals or a healthcare provider in the public sector
  • the alignment of labeling and packaging with current pharma rules
  • the transition to a prescription system

Experts revealed that January’s changes also eliminated the provision that allowed medical marijuana to be administered only as a last resort. This, they believe, could increase access to the drug.

For instance, individuals suffering from PTSD may now have quicker access to the drug. Prior to the change, some patients with moderate to severe post-traumatic stress disorder had to be diagnosed for no less than three years to become eligible for medical marijuana. This period has been reduced to 12 months.

Experts also believe that the changes announced in January, which went into effect immediately, will help drive growth in this industry. This can be seen in the recent data released by the Ministry of Health, which shows that in December 2023, about 2,800 new patients received medical cannabis licenses. The previous month, a total of 3,254 new patient licenses were also awarded.

A report by Prohibition Partners set the value of Israel’s medical marijuana market at about $340 million. This makes it one of the biggest nationally regulated medical cannabis markets globally. Prohibition Partners, a data and market intelligence company based in London, is focused on connecting the industry and offering data analytics, specialist information and digital commerce solutions.

The easing of restrictions in Israel is likely to be welcomed by cannabis companies such as TerrAscend Corp. (TSX: TSND) (OTCQX: TSNDF) as the changes enable accessibility to needed medical cannabis treatments.

TerrAscend Corp. (TSNDF), closed Monday's trading session at $1.98, off by 9.1743%, on 484,259 volume. The average volume for the last 3 months is 2.126M and the stock's 52-week low/high is $1.29/$2.45.

Cronos Group Inc. (CRON)

InvestorPlace, Schaeffer's, Kiplinger Today, MarketClub Analysis, The Street, StocksEarning, MarketBeat, Daily Trade Alert, Trades Of The Day, QualityStocks, Wealth Insider Alert, The Online Investor, Market Intelligence Center Alert, StockMarketWatch, StreetInsider, StockEarnings, BUYINS.NET, Zacks, The Wealth Report, Investopedia, Top Pros' Top Picks, Stock Up Featured, Cabot Wealth, InvestmentHouse, Daily Profit, Early Bird, InsiderTrades, Jim Cramer, The Rich Investor, InvestorsObserver Team, Wall Street Window, InvestorsUnderground, Money Morning, TheTradingReport, 24/7 Trader, Small Cap Firm, Stock Gumshoe and VectorVest reported earlier on Cronos Group Inc. (CRON), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

A recently amended measure, HB 698, advanced by a Virginia Assembly subcommittee, seeks to permit existing medical cannabis dispensaries and certain small businesses to commence recreational marijuana sales in January next year, with more retailers expected to be licensed by year-end.

A medical marijuana operator has to quickly establish six microbusinesses to capitalize on an early launch date. The present form of the law would provide $400,000 in funding to each of these microbusinesses. In turn, microbusiness licenses would require that at least two-thirds of the individuals directly controlling the enterprise meet certain social-equity requirements, with preference going to those who meet multiple requirements.

Delegate Paul Krizek, the subcommittee chair and the bill’s lead sponsor, noted that his proposal draws inspiration from Maryland’s approach to legal sales, including a gradual marketplace rollout. The bill is designed to ensure affordability through low taxes (9%), utilizing medical companies to address initial demand and implementing a robust social program to assist individuals most affected by cannabis criminalization.

Equity activists applauded the inclusion of prior cannabis misdemeanor convictions and people related to someone convicted (spouse, child, parent or sibling) as substantial additions to the qualifying requirements for microbusiness licenses. Additional criteria involve residence in historically underprivileged neighborhoods, school attendance in such areas, receiving Pell grants, or military veteran status.

The accelerator might be able to sustain 30 microbusinesses, given that Virginia currently has five medical cannabis providers. However, the measure would eventually allow more licenses for different marijuana-related activities.

Despite varied perspectives, there is general agreement that market control is necessary following the legalization of cannabis home cultivation, possession and use in 2021. Currently, legislators are trying to reach an agreement on a proposal regarding retail sales, despite the possibility of a veto from Governor Glenn Youngkin, who stated last month that he had no interest in legalizing Democratic-led sales bills.

When he assumed office, Gov. Youngkin stated that he was not opposed to permitting commercial sales in general. However, he noted that there were several Democratic measures, such as clauses requiring cannabis businesses to form labor unions, that he would not support.

Krizek’s amended measure is unique for allowing Virginia’s five existing medical cannabis companies to start recreational sales before new retailers receive licenses. While advocates argue that this speeds up the state’s legal marijuana sales, detractors warn that it would unfairly favor large out-of-state medical businesses over small and local enterprises.

Several advocacy organizations, such as Marijuana Justice and the Virginia chapter of NORML, are in support of the measure. Established cannabis companies such as Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) could also support the draft law because it would expedite access to licensed marijuana products instead of having customers taking chances with black-market products.

Cronos Group Inc. (CRON), closed Monday's trading session at $2.17, off by 1.81%, on 1,522,433 volume. The average volume for the last 3 months is 33,319 and the stock's 52-week low/high is $1.64/$2.64.

Bravo Multinational, Inc. (BRVO)

QualityStocks, RedChip, Buzz Stocks, SuperStockTips, Beacon Equity Research, Planet Penny Stocks, Profitable Trader Authority, OTCtipReporter, Penny Stock Titans, PennyStockScholar, Small Cap Firm, Nathan Gold, Stock Preacher, Epic Stock Picks, StockRockandRoll, Penny Pick Finders, MegaPennyStocks, InvestorSoup, Penny Stock 101, Penny Stock Craze, Penny Stock Finder, Penny Stock General, Penny Stocks Finder, PennyStockLocks, PennyStockProphet, TopPennyStockMovers, ProTrader, Shiznit Stocks, SmallCapGrowth, Stock Beast, Stock Commander, StockOnion, StockRunway and reported earlier on Bravo Multinational, Inc. (BRVO), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Bravo (OTC: BRVO) recently announced it has entered into an agreement to acquire the assets of Streaming TVEE, Inc., which stands at the forefront of licensed streaming technology. The agreement, the announcement states, solidifies Bravo’s entry into streaming and establishes the business foundation for its previously announced flagship offering, TVee NOW(TM), a new streaming service slated for Beta launch in Q1 2024. TVee NOW(TM) will be available directly to consumers via the web on any connected TV (“CTV”), smartphone or tablet and intends to offer traditional broadcast TV, which encompasses cable and satellite networks through a joint venture with Pythia Experiences currently set to close at a later date. “Fueling this transformative journey is a commitment to technical innovation, where state-of-the-art features and cutting-edge technology converge to create a seamless and immersive streaming experience. Viewers can expect a user-friendly interface, enhanced streaming quality, and innovative features that elevate the entertainment quotient,” said Grant Cramer, CEO of Bravo.

To view the full press release, visit

About Bravo Multinational, Inc.

Bravo Multinational is actively exploring opportunities in the entertainment, hospitality and technology sectors with the goal of generating long-term value for its shareholders through high-growth business ventures. Currently focused on pioneering innovative solutions in the digital content landscape, Bravo’s goal is to provide cutting-edge and diverse content experiences to a global audience.

Bravo Multinational, Inc. (BRVO), closed Monday's trading session at $0.2201, up 22.2778%, on 15,500 volume. The average volume for the last 3 months is 35.267M and the stock's 52-week low/high is $0.0445/$0.95.

Fisker Inc. (FSR)

Schaeffer's, InvestorPlace, QualityStocks, StocksEarning, MarketBeat, MarketClub Analysis, StockEarnings, The Street, Kiplinger Today, The Online Investor, Early Bird, Daily Trade Alert, GreenCarStocks, Trades Of The Day, Money Wealth Matters, TradersPro, Investopedia, 360 Wall Street, The Night Owl, wyatt research newsletter, Louis Navellier, InsiderTrades, INO Market Report, TipRanks, DividendStocks, StreetInsider, CNBC Breaking News, Cabot Wealth and InvestorsUnderground reported earlier on Fisker Inc. (FSR), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

During the National Automobile Dealers Association’s annual automotive show last week, Fisker Inc. (NYSE: FSR) CEO explained his dealership partnership model for their recently launched electric vehicle. Henrik Fisker talked about the Fisker Ocean Extreme, the company’s new electric SUV that is said to be affordable as well as exciting. The SUV will retail at $35,000.

Fisker also revealed that the company was working on a mid-sized electric pickup truck dubbed the Fisker Alaska. This new highly advanced, all-electric, four-door pickup truck is incredibly powerful and versatile. The truck is said to be affordable, with sales starting at $45,000.

Fisker noted that affordability was the company’s primary focus when it came to electric vehicles, noting that his objective was to develop exciting vehicles that people wanted and could afford. He added that while there were about 200 dealerships that had shown interest in its dealer partnership model, Mills Automotive Group clinched the top spot. Mills Automotive is based in North Carolina and hosts a solid selection of vehicles from major brands globally.

Fisker’s automotive background includes stints at BMW and Aston Martin. His cars are designed around unique features that will capture people’s attention. For instance, the Fisker Ocean Extreme has a range of 360 miles, the longest range among electric vehicles currently on the market. This electric vehicle also has a huge solar sky roof that will help generate 2,000 free miles annually from the sun. In addition, the vehicle is equipped with California mode, which affords its user a convertible-like experience by opening all the windows. This includes the rear quarter windows, rear lift gate window and the sliding roof.

Other future-forward features of the EV include its innovative Revolve rotating center screen that can swivel from Hollywood mode to control mode, allowing users to enjoy videos and movies, complete with 360-degree sound. Fisker also revealed that the Ocean was the most sustainable vehicle on the market, manufactured with roughly 110 pounds of recycled materials. He then noted that while all these differentiators were great, he was relying on the customer service and expertise of the franchise auto dealer network to help get his electric cars to market faster.

The Fisker Ocean comes in two other models: the Fisker Ocean Ultra and the Fisker Ocean Sport. The ultra’s starting price stands at $52,999 while the sport’s price starts at $38,999.

Fisker Inc. remains committed to efficiency and innovation, and providing zero-emission, electric fleets using advanced technology to meet individual and business needs.

Fisker Inc. (FSR), closed Monday's trading session at $0.7907, up 0.906075%, on 52,063,576 volume. The average volume for the last 3 months is 29.661M and the stock's 52-week low/high is $0.7255/$7.8585.

Riot Blockchain Inc. (RIOT)

Schaeffer's, MarketClub Analysis, InvestorPlace, StocksEarning, QualityStocks, StockMarketWatch, INO Market Report, MarketBeat, TradersPro, Zacks, Market Intelligence Center Alert, The Street, The Online Investor, Kiplinger Today, StockEarnings, TraderPower, InvestorsUnderground, Early Bird, AllPennyStocks, BUYINS.NET, Trades Of The Day, Investment House, Daily Trade Alert, PennyStockLocks, Market Intelligence Center, BillionDollarClub, MarketMovingTrends, Penny Stock 101, StockRockandRoll, StreetAuthority Daily, The Wealth Report, Trading Tips, Louis Navellier, Jeff Clark Research, Promotion Stock Secrets, Investors Alley, StreetInsider, The Daily Market Alert, DividendStocks, TopPennyStockMovers and Money Morning reported earlier on Riot Blockchain Inc. (RIOT), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Thailand’s finance ministry recently announced plans to waive value-added tax, or VAT, on transactions involving digital assets, demonstrating the country’s efforts to become a major player in the market. The move intends to support the Thai digital asset sector and promote the use of digital assets for fundraising, as reported in a recent Bangkok Post article.

To facilitate this, the ministry has lifted the 7% VAT requirement on income from digital tokens and crypto trading, effective Jan. 1, 2024. The VAT exemption has no set expiration date, offering dealers and investors involved in the digital asset realm a long-lasting incentive.

Notably, the VAT exemption for transferring digital investment assets to third parties has been in effect since May 14 last year. This exemption, which was previously exclusive to approved exchanges, is now available to dealers and brokers that are governed by Thailand’s Securities and Exchange Commission (SEC).

To strengthen the country’s position as a center for digital assets, the SEC and finance ministry are amending the Securities and Exchange Act of 2019. These changes will give digital assets the same legal standing as securities, promoting investor security and regulation. The new tax laws are expected to breathe new life into Thailand’s digital asset sector, which has been a popular destination for overseas investors in digital assets.

Additionally, Thailand’s SEC has loosened some of the prohibitions on investments using digital tokens by updating its criteria. The commission’s committee recently approved guidelines intended to improve investment rules and requirements for companies that deal with digital assets, with the aim of recognizing hazards related to digital assets and putting in place strong measures for protecting investors.

For example, the commission has removed prior investment restrictions placed on retail investors with regard to digital tokens linked to revenue streams or infrastructure operations (infra-backed ICOs) and those backed by real estate or producing income from real estate (real estate-backed ICOs). Before, the most that a retail investor could invest in a single offering was 300,000 baht ($8,357.9).

Moreover, the SEC reviewed requirements for starting businesses related to custodial wallet provision, allowing them to serve operators of digital asset enterprises. However, the commission has explicitly stated its refusal to permit the trading of Bitcoin spot ETFs within Thailand, despite their approval in the United States. This marks a notable shift in stance following years of hesitancy attributed to various cryptocurrency-related risks.

Thailand is taking a proactive approach to facilitating the growth of the crypto industry within its borders. Enterprises such as Riot Blockchain Inc. (NASDAQ: RIOT) would prefer that the jurisdictions in which they operate also adopt stable regulatory regimes to give clarity to industry actors.

Riot Blockchain Inc. (RIOT), closed Monday's trading session at $15.92, up 9.4158%, on 41,246,832 volume. The average volume for the last 3 months is 33,872 and the stock's 52-week low/high is $5.16/$20.65.

The QualityStocks Company Corner

Turbo Energy S.A. (NASDAQ: TURB)

The QualityStocks Daily Newsletter would like to spotlight Turbo Energy S.A. (NASDAQ: TURB).

Turbo Energy (NASDAQ: TURB), a Spain-based energy storage innovator, maintained a streak of success in 2023 despite challenges in the self-consumption photovoltaic sector. "June witnessed the launch of its SunBox Industry product line, a strategic move targeting the commercial and industrial self-consumption market. In September, Turbo Energy successfully raised $5 million with its American Depositary Shares debiting on the Nasdaq Capital Market. October marked a milestone with the company securing a patent in Spain for its innovative residential photovoltaic software. November brought about a strategic partnership with Leroy Merlin and the introduction of Turbo Energy's GoSolar offering through a collaboration with Movistar, a telecommunications leader in Spain and Latin America. Leadership changes saw the appointment of Mariano Soria as CEO in a bid to cement the company's vision for the future," a recent article reads. "Despite industry challenges, Turbo Energy maintains an optimistic outlook. With decreasing prices of photovoltaic components, the company anticipates robust global sales growth in the coming years. Its focus on AI-driven energy optimization and diverse product offerings places it strategically at the industry forefront."

To view the full article, visit

One of the deepest mines in Europe is poised to spend the next portion of its life as stationary energy storage. Located in Pyhäjärvi, a remote Finnish community 279 miles north of Finland's capital Helsinki, the 1,400-plus-meter-deep copper and zinc mine was decommissioned in 2022 after more than 50 years of service. The mine opened in 1962 and extracted more than 60 million tons of zinc and copper ore over its decades-long lifetime. The mine was a major employer through the years, and its closure led to the loss of many jobs in the local community. With many more for-profit companies such as Turbo Energy S.A. (NASDAQ: TURB) establishing themselves as major players in the renewable-energy space, innovations such as the storage of these energies in disused mines could play a crucial role in making renewables available 24/7.

Turbo Energy S.A. (NASDAQ: TURB) designs, develops and distributes equipment for the generation, management and storage of photovoltaic energy in Spain, Europe and internationally.

Turbo Energy’s products include lithium-ion batteries and inverters. Additionally, the company recently launched its flagship product, the Sunbox, an all-in-one device that integrates most of the equipment required for a residential photovoltaic installation. The Sunbox is powered by AI and features a software system that monitors the generation, use and management of photovoltaic energy by analyzing large amounts of data related to energy generation, consumption, market prices and weather forecasts. This AI system optimizes battery usage, reducing electricity bills and providing peak-use reduction and uninterruptible power supply functions.

Turbo Energy currently sells its photovoltaic energy equipment primarily through distributors for residential consumers in Spain, but it possesses the expertise and international perspective to expand its product portfolio into industrial and commercial scale and markets, as well as advancing the internationalization process it has already started. The company plans to expand into the industrial photovoltaic sector with its new Sunbox, launched in 2023, in higher power and capacity variants. Its goal is to become a significant player in this sector and contribute to the growth of renewable energy solutions.

The company was incorporated in 2013 and is based in Valencia, Spain. It operates as a subsidiary of Umbrella Solar Investment S.A.


Lithium-Ion Batteries

Turbo Energy is one of the leading companies that introduced lithium-ion batteries for photovoltaic energy storage in Spain. Primarily for the home energy storage market, the company’s batteries have capacities from 2.24 kWh to 5.1 kWh in 24 and 48 volts. In addition, its 48V / 5.1 kWh units are available in a dual battery system.


The inverter converts the direct current produced by the photovoltaic panels into alternating current that can be used by household appliances. It also regulates battery charging and discharging based on energy needs and optimizes utilization of generated renewable energy. Turbo Energy currently offers multiple models that cover most household installations.

All-in-One Sunbox

This product incorporates inverters, batteries and the rest of the components necessary to operate and protect the photovoltaic installation. This saves installation cost and assembly and configuration time while preventing errors. Notably, the latest Sunbox models also offer an EV charging option.

Software System

In communication with the inverter, the company’s software monitors energy flows between the photovoltaic panels, household consumption, storage and an optional electric vehicle charging station. The software allows users to customize an automatic backup mode based on weather forecasts, or manually select which part of the battery will be reserved for possible power outages. It also allows the battery to be used in a peak shaving mode, which leverages AI to trigger battery power when grid energy is most expensive, effectively reducing the amount of high-cost power drawn from the grid.

Market Opportunity

According to a report by Fortune Business Insights, a global research and reporting firm, the solar energy storage battery market was estimated to be worth $3.33 billion in 2022 and is projected to reach a value of more than $20 billion by 2030, marking a CAGR of 24.2% over the forecast period.

These batteries are crucial components of renewable energy systems, allowing for the storage of excess electricity generated by solar panels, so it can be used during times of no or low sunlight. By storing energy and supplying it when needed, these batteries reduce reliance on the power grid and maximize self-consumption while helping users avoid peak electricity rates. They also contribute to the transition toward a cleaner and more sustainable energy future by enabling residential consumers and businesses to use solar power even when the sun is not shining.

Management Team

Enrique Selva Bellvís is the CEO and founder of the Umbrella Group. In addition, he serves as vice-president of the Valencian Association of Energy Sector Companies industry group. Before his career in the solar energy sector, he was the founder and CEO of Innova Ingenieros Consultores. He holds a degree in industrial engineering with a specialization in energy from the Polytechnic University of Valencia and completed the Management Development Programme at the IESE Business School.

Mariano Soria is the Chief Innovation Officer for the Umbrella Group and serves as General Manager of Turbo Energy. He was CEO of Punt Moble XXI S.L. and continues to serve on that company’s board. Before that, he was the General Manager of REJMAR S.A., a land development company. He received his degree in industrial engineering and industrial organization from the Polytechnic University of Valencia, and his MBA from the European University of Madrid.

Alejandro Moragues is CFO of Turbo Energy. Previously, he held the position of Senior Corporate Auditor for U.S. company Euronet Worldwide Inc. and was an external auditor for PricewaterhouseCoopers. He holds a bachelor’s degree in business administration and management from the Polytechnic University of Valencia.

Manuel Cercos is Chief Commercial Officer at Turbo Energy. Previously, he held positions at Técnicas Aplicadas en Baterías S.L., where he served as Sales Director and Sales Manager. Before that, he worked as a Sales Technician at DAISA.

Turbo Energy S.A. (NASDAQ: TURB), closed Monday's trading session at $1.27, up 33.0818%, on 158,199 volume. The average volume for the last 3 months is 2.359M and the stock's 52-week low/high is $0.855/$7.90.

Recent News

SenesTech Inc. (NASDAQ: SNES)

The QualityStocks Daily Newsletter would like to spotlight SenesTech Inc. (NASDAQ: SNES).

SenesTech (NASDAQ: SNES), the leader in fertility control to manage animal pest populations, has been accepted as a vendor for all Ace Hardware stores, which form a network comprising over 4,500 locations. According to the announcement, all Ace Hardware stores will be able to order directly from SenesTech, and the company will participate in Ace Hardware's vendor events, including the Ace semi-yearly markets. "We are excited to be working with Ace Hardware. They represent leaders in the retail market for do-it-yourselfers and the consumer market, for which our Evolve(TM) soft bait is uniquely positioned," said SenesTech's President and CEO Joel Fruendt. "This is the first major move we will make into the retail market. We have expanded our packaging to include stand-up pouches, which are the perfect solution for the retail space. We are also in discussions with various rep agency firms that specialize in representing brands to major retailers and industrial/agricultural suppliers, to represent our line, as this will accelerate our penetration into this market segment."

To view the full press release, visit

SenesTech Inc. (NASDAQ: SNES) is the rodent fertility control expert and the inventor of the only EPA-registered contraceptive for male and female rats. The company’s technology provides an innovative and humane method for managing rat populations.

SenesTech is focused on developing effective solutions that are grounded in science and proven through research, all while providing value to people, communities and the environment. The company’s passion is to create a healthier world by better controlling rat pest populations. This aim is critical, as, if left unchecked, a breeding pair of rats and their descendants can produce up to 15,000 pups after just one year.

The company strives for clean cities, efficient businesses and happy households – with a product that was scientifically designed to be effective without killing rats. SenesTech is committed to the sustainable, humane treatment of animals, improving the quality of all human life and enhancing environmental stewardship through the global application of its effective solution in fertility control technology.

SenesTech is headquartered in Phoenix, Arizona.


SenesTech’s first product, ContraPest®, applies revolutionary technology to a global challenge that has persisted since the Middle Ages – the proliferation of rats in urban and agricultural settings. ContraPest® targets the reproductive capabilities of Norway and roof rats. As a highly palatable liquid, the formulation promotes sustained consumption, helping to reduce fertility in both male and female rats, bringing populations down and keeping them down.

The company’s flagship offering can be used as part of integrated pest management (IPM) programs – fitting seamlessly into all IPM programs – to help reduce reproduction and magnify the success of these protocols, or as a standalone solution for customers who want to reduce or eliminate the use of lethal rodent control methods.

In multiple, independent field deployments, ContraPest was shown to reduce rat activity over 90% when added to an existing IPM program.

ContraPest® is registered federally as a General Use Product.

Delivery Systems and New Products

In July 2023, SenesTech began to distribute a new delivery system for ContraPest®, the Isolate Bait System™. This new delivery system brings to market a simple design that enables more efficient deployment, incorporates an enhanced formulation of ContraPest® that is expected to provide improved performance of the fertility control bait in the field and is paired with a new bait station that is more space-efficient and economical.

The other delivery systems available for ContraPest include the Ultimate Bait System™, a tank and tray in a larger format for use with more severe infestations, and the Elevate Bait System™, a unique delivery system that targets above ground infestations, as with roof rats.

SenesTech, as of August 2023, is also in the final stages of releasing a soft bait formulation, which provides the unique attributes of proven fertility control in an industry-familiar format demanded by big box retailers, key e-commerce channels and leading industry pest management professionals.

Market Opportunity

According to SenesTech’s figures, rats cause over $27 billion in damage to public and private infrastructure annually in the United States. Rats also destroy 20% of the global stored food supply every year by consuming or contaminating it.

Rats are known to spread at least 35 diseases, globally posing a dangerous risk to public health and safety. Not only does this age-old problem persist despite extensive campaigns to eradicate it, but multiple sources have reported that post-COVID rat populations have boomed.

Poison-based control methods sicken rats, and they typically die slowly. An animal that eats a poisoned rat may also sicken or die. The global rodenticide market is projected to be worth $1.7 billion by 2026.

In one case study, results reported by the customer showed a $5,000 investment in ContraPest® saved more than $500,000 annually in reduced labor, loss and damage.

Management Team

Joel Fruendt is SenesTech’s President and CEO. He has 15 years of executive leadership in the vector and pest control industries as Vice President and General Manager of Clarke Environmental Inc., a leading vector and pest control products and services company. He has extensive expertise in the development and manufacturing of EPA-registered chemical control products, and the commercialization and sale of those products. He received the ‘Smart Leaders’ award from Smart Business Magazine and holds a bachelor’s degree in business from Illinois Wesleyan University.

Tom Chesterman is CFO at SenesTech. He has over 20 years of experience as the CFO of public companies in the life science, tech and telecommunications industries. Most recently, he was the Vice President and Treasurer of GCI, a telecommunications company. Previous to that, he was the CFO of life science companies Bio-Rad Laboratories, Aradigm and Bionovo. He has a bachelor’s degree from Harvard University and an MBA from the University of California at Davis.

Dan Palasky is Chief Technical Officer at SenesTech. Previously he held the title of Vice President of Research & Development at PLZ Corp., a manufacturer of chemical consumer products, serving as the technical expert for its entire product portfolio. He started his career with Camie-Campbell, Inc., as a chemist in the R&D department. Mr. Palasky received his bachelor’s degree in chemical engineering from the Missouri University of Science & Technology and his MBA in Project Management from Aspen University.

SenesTech Inc. (NASDAQ: SNES), closed Monday's trading session at $1.19, up 12.2642%, on 2,423,966 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $7.90/$.

Recent News


The QualityStocks Daily Newsletter would like to spotlightFathom SOBRsafe Inc. (NASDAQ: SOBR).

SOBRsure sales activities in Australia and New Zealand have been initiated through an international channel partnership with Drug Testing Business Success

Drug Testing Business Success has a 14-year history representing the world's most widely-used ankle bracelet for alcohol detection

The global alcohol sensor market was valued at $2.3 billion in 2022, and is expected to reach $6.3 billion by 2030

SOBRsafe's products are geared toward behavioral health, justice, and consumer markets – and well-positioned for licensing and integration

SOBRsafe (NASDAQ: SOBR), a provider of next-generation transdermal alcohol detection solutions, recently announced that it has initiated SOBRsure(TM) sales activities in Australia and New Zealand through an international channel partnership with Drug Testing Business Success – the region's leading drug and alcohol testing provider. Drug Testing Business Success has extensive experience in the transdermal alcohol detection industry, representing the world's most widely-used ankle bracelet for 14 years (

SOBRsafe Inc. (NASDAQ: SOBR) is a provider of a game-changing transdermal (touch-based) alcohol detection technology that can improve workplace safety and provides advanced screening and monitoring solutions for the behavioral health industry.

Alcohol misuse is the fourth leading cause of preventable death in the U.S., and the seventh worldwide. Nearly half of all industrial accidents with injuries are alcohol-related, and 1-in-10 U.S. commercial drivers tests positive for alcohol – the highest rate in the world. Despite these statistics, prevention and monitoring solutions have not kept pace with this epidemic. Legacy detection technologies are invasive and inefficient, unhygienic and unconnected. SOBRsafe believes there is a better way.

The company has developed a patent-pending alcohol detection device called SOBRcheck™ for use in detecting alcohol in humans, with just the touch of a finger. SOBRsafe’s next-generation transdermal technology detects and instantaneously reports the presence of alcohol as emitted through a user’s skin. No breath, blood or urine sample is required. SOBRsafe believes its technology is a superior, hygienic alternative to traditional breathalyzers for frontline, preventative applications.

With a powerful backend data platform, SOBRsafe provides humane, passive and connected alcohol detection for the behavioral health, transportation, oil and gas, judicial and consumer markets.

A preventative solution in historically reactive industries, SOBRsafe technology is being deployed for commercial fleets, workplaces, alcohol rehabilitation, probation management and teen drivers. This monitoring technology helps prevent intoxicated workers from taking the factory floor or drivers from receiving the keys to a truck, bus or family car. An offender is immediately flagged, and an administrator is empowered to take the appropriate corrective actions.

SOBRsafe technology is commercially available for access control (SOBRcheck), wearable use (SOBRsure™) and licensing or white labeling.

The company is headquartered in the Denver (CO) Technology Center.


The SOBRsafe technology is integrated within the company’s robust and scalable data platform, producing statistical and measurable user and business data.


With a mission is to save lives, increase productivity, create significant economic benefits and positively impact behavior, SOBRsafe developed the scalable, patent-pending SOBRsafe™ platform for non-invasive alcohol detection, real-time reporting and historical data aggregation.

SOBRsafe is a solution that has broad applications in behavioral health, fleet and facility safety, youth drivers and judicial markets.


SOBRcheck is the company’s stationary identification and alcohol monitoring product, providing a quick, specific-point-in-time test for the presence of alcohol. In hygienic, real-time fashion, SOBRcheck verifies user identity and determines the absence or presence of alcohol.

SOBRcheck provides an administrator immediate results – delivered securely – to aid in the efficient management of an existing substance abuse policy.


SOBRsure is the company’s transdermal, alcohol-detecting wearable. SOBRsure provides continuous, mobile alcohol monitoring. The band’s advanced alcohol safety technology discreetly detects and instantaneously reports the presence of alcohol in the body. Additionally, SOBRsure provides app-based alcohol detection alerts, pinpoint location tracking and band-removal notifications.

The SOBRcheck and SOBRsure revenue models consist of two components: (1) a hardware device purchase and (2) a recurring monthly SaaS subscription fee.

Design, manufacturing, quality testing and distribution for all SOBRsafe devices takes place in the U.S.


Market Opportunity

A report from Data Bridge Market Research, an international market research and consulting firm, estimated the global alcohol sensor market at $2.3 billion in 2022. The market is forecast to reach a value of $6.3 billion by 2030, recording a CAGR of 13.7% over the forecast period.

Market growth drivers, as cited by the report, include rising alcohol consumption rates, more stringent laws pertaining to alcohol consumption and new, more effective technologies that facilitate detection and enforcement.

Greater awareness of alcohol consumption as a potential threat to public and workplace safety has led to increased emphasis on preventing operation of motor vehicles and machinery by those under the influence of alcohol and promoting responsible alcohol consumption, as the report details.

Management Team

David Gandini is Chairman and CEO of SOBRsafe. He most recently served as president of IPS Denver, a bank card personalization company. Prior to that, Dave was the COO at First World Communications, a U.S. internet and data center provider, and participated in its successful IPO. He previously founded Pace Network Services and facilitated a successful exit to ICG Communications. Dave also co-founded Detroit-based Digital Signal in the fiber optic long haul market sector, where he executed a successful exit to SP Telecom.

Chris Whitaker, CPA, is CFO of SOBRsafe. Previously, Chris had served as the Company’s Vice President of Finance and Accounting. He has held various executive finance positions with large public multi-national corporations and small entrepreneurial companies throughout a progressive 30-year career that began with KPMG. Chris was formerly President – Americas and Vice President of Finance and Administration for public, multinational corporation Elixinol. He also served as the Managing Director of AEGIS Financial Consulting, leading a team of consultants in providing fractional CFO and financial consulting services to a wide variety of businesses in the public and private sectors.

Scott Bennett is EVP, Business Operations at SOBRsafe. He has more than 20 years of experience as a senior executive in technology-driven enterprises. Prior to joining SOBRsafe, he co-founded cybersecurity firm GBprotect and served as its COO until its successful sale to Nuspire. He previously served as Chief Technical Officer/Chief Information Security Officer of fintech businesses Catalyst Card Company and Integrated Printing Solutions.

SOBRsafe Inc. (NASDAQ: SOBR), closed Monday's trading session at $0.7202, up 4.3768%, on 43,528 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $0.2004/$3.16.

Recent News

SuperCom Ltd. (NASDAQ: SPCB)

The QualityStocks Daily Newsletter would like to spotlight SuperCom Ltd. (NASDAQ: SPCB) .

SuperCom (NASDAQ: SPCB), a global provider of secured solutions for the e-government, Internet of Things ("IoT") and cybersecurity sectors, has secured a new contract with an established California services provider in the judicial sector. According to the announcement, the contract is already operational and generating revenue; it also has long-term growth potential. SuperCom was awarded the contract over a long-time incumbent competitor, a reflection of the potential for the company's new PureOne solution as well as its vision of expanding its footprint in the U.S. market and the competitive edge provided by delivering superior technology solutions. "We are pleased to announce a second new contract in North America since the start of 2024, reflecting momentum and reputation in the industry," said SuperCom CEO and president Ordan Trabelsi in the press release.

"This collaboration showcases not only our ability to compete in the market successfully but also our commitment to innovation and customer satisfaction. Introducing our PureOne solution was a game-changer in securing this contract. It underscores our competitive edge and commitment to providing innovative and superior technology solutions. By securing this contract and displacing an incumbent competitor, we further reinforce our position as a market leader. We view our recent wins as indicators of our growing influence and expansion potential in North America and worldwide."

To view the full press release, visit

SuperCom Ltd. (NASDAQ: SPCB) provides secured solutions for the e-government, IoT and cybersecurity sectors. Since 1988, the company has been a trusted global provider of traditional and digital identity offerings, providing cutting-edge electronic and digital security solutions to governments and organizations, both private and public, around the world.

SuperCom’s mission is to revolutionize the public safety sector worldwide through proprietary electronic monitoring technology, data intelligence, and complementary services.

The company is headquartered in Tel Aviv, Israel, with offices in California and other regions in the U.S.

Business Units

IoT and Connectivity

SuperCom IoT products and solutions provide advanced electronic monitoring solutions and services to criminal justice agencies, enabling customers to detect unauthorized movement of people, vehicles, and other monitored objects. The company provides an all-in-one, field-proven PureSecurity offender monitoring suite, accompanied by services such as GPS monitoring, home detention, domestic violence prevention, and more. The company’s services are specifically tailored to meet each client’s needs.

SuperCom’s proprietary Puresecurity suite of hardware, connectivity, and software components is the foundation for its criminal justice services and offerings. SuperCom is leveraging its extensive technology expertise to implement groundbreaking artificial intelligence (AI) technologies into various parts of its core offerings. By leveraging the power of AI, SuperCom’s PureSecurity platform can offer new abilities, such as amplified data analysis, predictive modeling, and streamlined automation – all geared toward optimizing decision-making and operational efficiency.

Competitive advantages of SuperCom’s technology include:

  • Long Battery Life (No Tag Charging Required)
  • Ultra Lightweight Form Factor
  • Next-Gen Location Tech
  • Protection of Domestic Violence Victims
  • And More



In 2015, SuperCom identified the cybersecurity market as a fast-growing space with significant advantages due to synergistic technologies and a shared customer base with its e-Gov and IoT business units. Consequently, SuperCom strategically acquired Prevision Ltd., a company with a strong presence in the market and a broad range of competitive cybersecurity services.

During the first quarter of 2016, SuperCom acquired Safend Ltd., an international provider of cutting-edge endpoint data protection guarding against corporate data loss and theft through content discovery and inspection, encryption methodologies, and comprehensive device and port control.

Both acquisitions significantly expanded the breadth of the company’s global cybersecurity capabilities.


Through proprietary e-government platforms and innovative solutions for traditional and biometrics enrollment, personalization, issuance, and border control services, SuperCom has helped governments, and national agencies design and issue secured multi-identification, or Multi-ID, documents and robust digital identity solutions to their citizens, visitors, and lands.

The company has focused on expanding its activities in the traditional identification, or ID, and electronic identification, or e-Gov, markets, including the design, development, and marketing of identification technologies and solutions to governments in Europe, Asia, America, and Africa using SuperCom’s e-Government platforms.

Market Opportunity

Data from Berg Insight estimates the market for electronic monitoring solutions will grow from $1.2 billion in 2021 to $2.1 billion in 2026, marking a CAGR of 10.8% for the forecast period.

High recidivism rates, prison overcrowding, and soaring incarceration costs are some factors that are driving the electronic monitoring of offenders’ market growth.

An analysis by ReportLinker forecasts that the global cybersecurity market will grow from an estimated value of $173.5 billion in 2022 to $266.2 billion by 2027, achieving a CAGR of 8.9% for the period.

The increased number of data breaches worldwide, the ability of malicious actors to operate from anywhere in the world, the links between cyberspace and physical systems, and the difficulty of reducing vulnerabilities and consequences in complex cyber networks are some factors driving the cybersecurity market growth.

Management Team

Ordan Trabelsi is President and CEO of SuperCom. He has over 15 years of experience as CEO, growing high-tech companies globally. He also has experience in research and development and product innovation, as well as hands-on experience in cybersecurity, encryption, advanced mathematics, and mobile and internet network technologies. Prior to joining SuperCom, he served as co-founder and CEO of Klikot Inc., a global social networking company. He holds an MBA from Columbia University and a B.Sc. in Computer Engineering from The Technion: Israel Institute of Technology.

Barak Trabelsi is COO of SuperCom. He has expertise in big data, cyber, mobile, and internet network technologies, as well as extensive experience in product development and strategies. Prior to joining SuperCom, he served as Senior Product Manager at Equinox Ltd. Before that, he served for four years as VP of R&D at Sigma Wave, a wireless, security, and internet-focused company. He holds a B.Sc. in Computer Science and Business, as well as an MBA from Tel Aviv University.

Gil Alfi is VP of Sales at Safend Ltd., SuperCom’s cybersecurity subsidiary. He joined SuperCom in 2016 as VP of Business Development for Safend. He has more than 18 years of experience in technology companies. He served as an R&D team technology lead for more than seven years and as Director of Product Management for various telecom and wireless companies for more than 10 years. Prior to joining SuperCom, he served as Regional Sales Director at Safend, managing sales regions in Europe and Africa. He holds a B.Sc. in Computer Science and Mathematics and an M.Sc. in Computer Science from Bar-Ilan University.

SuperCom Ltd. (NASDAQ: SPCB), closed Monday's trading session at $0.2248, up 22.4401%, on 71,619,363 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $0.16/$2.22.

Recent News

Sekur Private Data Ltd. (CSE: SKUR) (OTCQB: SWISF) (FRA: GDT0)

The QualityStocks Daily Newsletter would like to spotlight Sekur Private Data Ltd. (CSE: SKUR) (OTCQB: SWISF) (FRA: GDT0).

Sekur Private Data (CSE: SKUR) (OTCQB: SWISF) (FRA: GDT0) provides secure and private communication services that allow governments, organizations and individuals to communicate sensitive information and data without compromising safety and integrity. "The average cost of a data breach globally in 2023 was $4.45 million, a 15% increase over three years. With the high cost of data breaches worldwide, Sekur's privacy communications suite of services was created to make secure communications affordable and available in monthly and yearly subscription plans. The company's solutions include: SekurMail(R) with SekurSend/SekurReply, an encrypted email service offering a private, safe and powerful tool to communicate with everyone within or outside the Sekur ecosystem; SekurVPN(R), which creates a secure, encrypted connection between clients' devices and the internet, giving safe access to the web by routing connections through the company's wholly-owned Swiss servers; and SekurMessenger(R), a Swiss-hosted private and secure messaging communications app that provides secure and private chat, self-deleting chat, voice recording, and file transfer via any mobile device, tablet or desktop computer," a recent article reads. "Sekur owns 100% of its infrastructure and, unlike its competitors, does not rely on third-party cloud services."

To view the full article, visit

Sekur Private Data Ltd. (CSE: SKUR) (OTCQB: SWISF) (FRA: GDT0) is a Cybersecurity and Internet privacy provider of Swiss hosted solutions for secure and private communications. The company distributes a suite of encrypted e-mails, secure messengers and secure communication tools. Sekur Private Data Ltd. sells its products through its own website at, approved distributors, and telecommunications companies. Sekur Private Data Ltd. serves consumers, businesses and governments worldwide.

Customer information is completely confidential and safely stored in Switzerland using military grade security. All data, whether physical, network-based or encryption security, is stored in bank-approved, state-of-the-art ISO-certified data centers used by Swiss and global banks and most United Nations organizations, as well as many corporations and governmental organizations. All user data is protected by the Swiss Federal Data Protection Act and the Swiss Federal Data Protection Ordinance, which offer some of the strongest privacy protection in the world for both individuals and organizations.

The company owns 100% of its own infrastructure and, unlike its competitors, does not rely on third party cloud services like Amazon Web Services, Microsoft Azure Cloud or Google cloud infrastructure.

Sekur Private Data has chosen Switzerland to locate its data storage because of the country’s neutrality, independence, strong privacy laws, long standing political stability and excellent international relations. Switzerland is also home to several large multinational corporations and is ranked as having one of the strongest and most competitive economies in the world.

The company is headquartered in Toronto, Ontario.


Sekur Private Data distributes a privacy communications suite offering encrypted and private email, the only Swiss-hosted privacy VPN, and a secure and private messaging application. All solutions cater to consumers, SMBs, enterprises and governments.

  • SekurMail® is an encrypted email service offering a private, safe and powerful tool to communicate with everyone, either within the Sekur ecosystem or outside. SekurMail protects personal information and communications from being accessed by unauthorized parties. Its encryption and other security measures prevent messages from being intercepted, modified or tampered with, either in transit or while stored. SekurMail empowers the client to access information and communicate with anyone in the world, regardless of geographical or political barriers.
  • SekurVPN® creates a secure, encrypted connection between the client’s device and the Internet, giving clients access to the web safely and privately by routing their connections through a server and hiding their online actions. All the data sent and received is hidden from prying eyes. This includes the clients’ Internet Service Providers, as well as potential hackers and even government surveillance agencies. It can also help clients bypass geographical restrictions and censorship.
  • SekurMessenger® is a Swiss-hosted private and secure messaging communications app providing secure and private chat, self-deleting chat, voice recording and file transfer via any mobile device, tablet or desktop computer. Communications are transmitted only within secure servers. It’s designed for organizations that need to protect their flow of information and secure their communications with customers and partners. SekurMessenger is designed to provide military-grade encryption and privacy by ensuring that only the sender and intended recipient can read the messages exchanged. It works for both licensed users of the app and intended message recipients who do not have the app.

Market Opportunity

An analysis from ReportLinker forecasts that the global cybersecurity market will grow from an estimated $173.5 billion in 2022 to $266.2 billion by 2027, recording a CAGR of 8.9% for the period.

The increased number of data breaches worldwide, the ability of malicious actors to operate from anywhere in the world, the links between cyberspace and physical systems and the difficulty of reducing vulnerabilities and consequences in complex cyber networks are some factors that are driving cybersecurity market growth, according to the report.

The global data privacy software market was estimated to be worth $1.68 billion in 2021 and is expected to grow from $2.36 billion in 2022 to $25.85 billion by 2029, achieving an eye-popping 40.8% CAGR during the forecast period, according to a Fortune Business Insights report titled ‘Data Privacy Software Market 2022-2029’.

The widespread shift toward remote working culture, evolving government data privacy regulations and the rapidly increasing adoption of Internet-of-Things devices are among the major factors propelling market growth, per the report.

Management Team

Alain Ghiai is founder, CEO and Director at Sekur Private Data. He also founded GlobeX Data S.A. (GDSA) in 2007 and has served as Director and CEO since then. He founded GlobeX Data Inc. (GlobeX US) in August 2012 and has served as Director and CEO since that time. He attended the California College of Arts in San Francisco, where he earned a Bachelor of Architecture. He has over 15 years of experience in the software industry and was instrumental in taking Sekur Private Data public in July 2019.

Scott Davis, CPA, CGA, is CFO at Sekur Private Data. He is also a partner at Cross Davis & Company LLP Chartered Professional Accountants. His experience includes CFO positions at several companies listed on the TSX Venture Exchange. He spent four years at Appleby as an Assistant Financial Controller. Prior to that, he spent two years at Davison & Company Chartered Professional Accountants as Auditor, five years with Pacific Opportunity Capital as Accounting Manager and two years at Jacobson Soda and Hosak, Chartered Professional Accountants. He obtained his CPA, CGA in 2003.

Learn more about the company’s management team by visiting its corporate page.

Sekur Private Data Ltd. (OTCQB: SWISF), closed Monday's trading session at $0.05083, up 5.7416%, on 900 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $0.036/$0.1576.

Recent News

Astiva Health

The QualityStocks Daily Newsletter would like to spotlight Astiva Health

Astiva Health, a leading healthcare provider that specializes in delivering personalized and comprehensive solutions to diverse communities, was spotlighted as a significant player in the Medicare Advantage Prescription Drug ("MAPD") sector in a recent episode of the Bell2Bell Podcast. "The episode featured an exclusive interview with Astiva Health's Co-Founder and CEO Dr. Tri Nguyen, a renowned expert in internal medicine and cardiology. During the interview, Dr. Nguyen discusses Astiva Health's journey since its inception in 2020 and its expansion plans. He shared insightful details about the company's expansion to Los Angeles, San Bernardino and Riverside, marking a pivotal phase in transforming healthcare delivery," a recent article reads. "One key highlight from the podcast was Astiva Health surpassing the 10,000-member milestone. Dr. Nguyen attributed this success to the company's philosophy, which emphasizes loving life at any age… Astiva Health's approach goes beyond providing medical care and prescription drugs. As Dr. Nguyen explains in the interview, it includes offering rich supplemental benefits to engage enrollees in a meaningful, healthy life. He emphasized the importance of patient involvement in successful medical outcomes, a cornerstone of Astiva Health's strategy."

To view the full article, visit

Astiva Health is a dynamic and innovative Medicare Advantage Prescription Drug (MAPD) health plan committed to reshaping the landscape of personalized and comprehensive healthcare. The company offers full medical, drugs, and supplemental benefits for Medicare enrollees, currently serving counties in California, including Orange, San Diego, Los Angeles, Riverside, and San Bernardino. This broad coverage reflects Astiva Health’s dedication to reaching a diverse demographic and addressing the healthcare needs of individuals across Southern California.

Astiva Health primarily serves a heretofore underserved Asian American and Pacific Islander population, which positions it in a critical and expanding market segment and offers substantial growth potential. The company recognizes the diverse needs within its served communities and strives to bridge healthcare gaps through proactive and culturally responsive solutions.

Astiva Health cares about its members and works to establish lifelong relationships with them by providing a tailored approach to healthcare, offering multilingual solutions for customer service, marketing materials and educational resources. Health is an essential key to living a good life, and Astiva Health makes it a priority to help members love the life they live.

The company’s mission is to deliver an unparalleled level of quality care to its members. Astiva Health’s Medicare Advantage plans provide lower costs and additional benefits beyond original Medicare coverage.

Founded in southern California, Astiva Health has strategically positioned itself in a region with a dynamic and diverse population. The organization’s extensive network and culturally responsive approach to healthcare make it well-suited to cater to the needs of the local community, creating a competitive advantage in the market.

The company is based in Orange, California.

Healthcare Model

Astiva Health is not just another health plan. The company considers the uniqueness of its members and, therefore, the means for delivering quality care to each one. To best serve its members, Astiva Health has developed one of the most diverse networks in southern California, offering a selection of medical, drugs, and supplemental benefits including dental, acupuncture, vision and hearing plans tailored to the specialized needs of individual members.

The company’s health plans provide increasing levels of benefits to members in the counties it serves. Astiva Health’s Customer Care Support and representatives are available to assist members with any issues.

The organization’s proactive approach to overcoming language barriers for the Vietnamese communities demonstrates a commitment to inclusivity and enhances accessibility – a key factor for future growth. The successful implementation of strategies for the Vietnamese community sets a precedent for Astiva Health’s ability to adapt and apply similar approaches to serve other ethnic groups in future expansions, broadening the potential impact of its services.

The company provides members access to experienced and dedicated providers and local pharmacies that work together with each member to pave a pathway toward better health. The company’s online directory provides members with a comprehensive list of providers to fit their specialized needs.

Astiva Health collaborates with a variety of partners who offer supplemental benefits to members beyond Medicare. Those benefits include transportation, vision, dental, hearing, fitness, tele-health, acupuncture and chiropractic. Astiva’s forward-thinking strategy not only fulfills a critical societal need but also ensures sustainable growth and transformative impact across diverse communities.

Market Opportunity

Medicare Advantage plans, since their establishment in 2008 as a lower-cost alternative for Medicare enrollees looking to save on monthly premiums, have been one of the fastest growing segments of the health insurance market.

According to a report by healthcare consultant Charts, nearly 31 million beneficiaries are enrolled in a Medicare Advantage plan in 2023, accounting for more than 48% of the total Medicare market. That represents 9.6% enrollment growth over 2022 totals, and the pace of growth is likely to continue, according to the Charts report.
Startup Medicare Advantage plans, a sector that includes Astiva Health, grew even faster for 2023, at a rate of 22% over 2022 totals.

Management Team

Dr. Tri T. Nguyen is co-founder and CEO of Astiva Health. He is a graduate of Stanford Medical School and is a board-certified expert in internal medicine, cardiovascular disease and interventional cardiology. As founder, CEO and owner/operator of Avanta IPA, he is a committed leader in healthcare. His visionary leadership, hands-on experience and deep industry knowledge uniquely position him to guide Astiva to success.

Chi Luong is CFO at Astiva Health. She founded and operates HADD Group LLC, a company managing medical clinic services, including business contracting, finance, staffing and ancillary support for several medical clinics in San Diego. She is responsible for the expansion and daily operation of the business functions of the medical clinics managed by HADD Group, and she has extensive knowledge and experience in healthcare business development.

Viet Tran has over 30 years of experience in engineering research, development and management. He has made numerous contributions to national network security and technology. He led the initial Naval Interoperability Profiles that set a solid foundation for future naval airborne network development. He also led a team of 50 engineers, doctorates and scientists delivering an airborne network system for the Navy’s first carrier-based unmanned aircraft. As Astiva Health’s Chief Operating and Technology Officer, member satisfaction has been his top priority. He is committed to protecting valuable data for Astiva members and providers. He constantly strives for leaner and more effective operations.

Tyler Diep is Vice President, Sales, Marketing and Provider Relations at Astiva Health. His responsibilities include handling special projects for the board of directors, as well as overseeing the sales, marketing and provider relations department. During his tenure, he tripled the membership of Astiva Health. He previously served as councilman and vice mayor of the City of Westminster, California. He immigrated to the U.S. with his parents and graduated from San Diego State with a bachelor’s degree in public administration.

Recent News


Horizon Fintex | Upstream

The QualityStocks Daily Newsletter would like to spotlight Horizon Fintex | Upstream

Upstream, the revolutionary retail trading app for stocks and NFTs powered by Horizon Fintex and MERJ Exchange Limited, is working to create economic development for foreign exchanges and their issuers. As part of that focus, the company has announced its Exchange Dual Listing Program for 2024.

"As it stands today, it is difficult for international investors to buy U.S.- and Canadian-listed securities," a recent Upstream blog stated. "Retail investors outside the U.S. and Canada don't typically have streamlined access to purchase NASDAQ, NYSE, OTC, TSX, TSX.V, CSE or shares from smaller exchanges around the world without going through a cumbersome process. This may be limiting issuers' ability to raise capital, increase liquidity and access new investors."

To meet this need, Upstream is offering companies that are already listed on stock exchanges such as NASDAQ, NYSE, OTC, EURONEXT, ASX, NSX, TSX, CSE, LSE, etc., to dual list on Upstream, resulting in the ability to access a global, digital-first investor base that can trade their shares using an app from anywhere in the world.

To view the full blog, visit

Horizon Fintex is a software business specializing in compliant securities solutions. The company aims to facilitate the future of capital markets by leveraging the regulatory experience of Wall Street bankers and the proven track record of technology veterans to bring focus to compliance, efficiency, security and transparency.

Horizon’s flagship product is the revolutionary trading app ‘Upstream’, a MERJ Exchange Market, and the first regulated market powered by a blockchain to offer both digital securities and NFT trading. Upstream traders experience T+0 settlement, best bids and offers displayed on a transparent public orderbook that prevents predatory market practices – all from a user-friendly trading app.


Horizon Fintex offers a full suite of end-to-end blockchain-enhanced software solutions to create a seamless experience for both issuers and investors. Its product suite includes:

  • Securitization & IssuanceETSware is an end-to-end Electronic Trading System streamlining capital raising from primary issuance through compliant secondary trading.
  • KYC Compliance OnboardingKYCware is a white label Know Your Customer (KYC) and Anti-Money Laundering (AML) compliance software solution offering best-in-class cryptographic security to compliantly onboard and verify user identity through a smartphone application.
  • AML Screening SoftwareAMLCop offers advanced Anti-Money Laundering (AML) software to streamline the verification of user details against a proprietary database of global sanctions, politically exposed persons (PEPs) and watchlists.
  • Cap. Table Management ToolsCustodyWare equips registered U.S. transfer agents with next-generation cap. table management software to manage securities on behalf of their clients pursuant to an SEC-registered or exempt securities offering.
  • Exchange & Trading App TechnologyOpen Order Book offers Ethereum blockchain securities exchange software to power the next generation of trading venues for digital assets.

Upstream – The Horizon-Powered Trading App

Upstream is a joint venture with MERJ Exchange (, an affiliate of the World Federation of Exchanges.

Upstream aims to be the premiere global trading hub offering issuers around the world exposure to a digital-first investor base that can trade using USDC digital currency along with credit, debit, PayPal, and USD (fiat) to increase liquidity and enhance price discovery; while also offering investors access to dual-listed companies, IPOs, crowdfunded companies, U.S. & Int’l. equities, digital coupons and NFTs directly from a user-friendly trading app.

Upstream aims to unlock liquidity for investors of all levels while offering industry-leading levels of transparency, accessibility and investor protections enforced using Ethereum blockchain technology.

Management Team

Brian Collins is the CEO of Horizon Fintex. He founded the company in 2010. From 1999-2010, Mr. Collins was CEO of Abbey Technology in Switzerland, specializing in the design of trading software for Swiss banks. Prior to this, he worked for Credit Suisse in Zürich, designing and building proprietary equity trading solutions. Mr. Collins graduated in 1990 with a BS in Computer Systems from the University of Limerick, Ireland.

Mark Elenowitz is the company’s President. He is a Wall Street veteran with over 29 years of experience. Mr. Elenowitz was the co-founder of a U.S. broker dealer and is Managing Director of two U.S. broker dealers, responsible for advising clients on compliance, capital structure and capital market navigation. He was responsible for leading the first successful Reg A+ IPO of a company to list on the NYSE and others which listed directly onto Nasdaq. He is a noted speaker at Small Cap and Reg A events, including the SEC Small Business Forum, and has been profiled in BusinessWeek and CNBC, as well as several other publications. Mr. Elenowitz is a graduate of the University of Maryland School of Business and Management with a BS in Finance and holds Series 24, 62, 63, 79, 82 and 99 licenses.

Dr. Andrew Le Gear is the CTO of Horizon Fintex. Prior to joining the company in 2013, he worked as a software engineer with Dell Inc. (2012-2013) and Lehman Brothers and Nomura Plc. (2007-2012). Dr. Le Gear was a co-founder of Juneberi Ltd., a research-driven software tech start-up (2004-2007). He graduated in 2006 with a Ph.D. in Computer Science from the University of Limerick, Ireland.

Peter Hall is the company’s CIO. Prior to joining Horizon Fintex in 2011, he worked at Microsoft (2008-2011), Atos Origin (2004-2008) and AIT Group Plc. (1998-2002). Mr. Hall has held CISSP certification since 2010. He graduated from the University of Sheffield, UK in 1995 and earned an MS from the University College London in 2006.

Mike Boswell is the CFO of Horizon Fintex. A Wall Street veteran, he co-founded a U.S. broker dealer and served as Chief Compliance Officer. Mr. Boswell was also Managing Director of TriPoint Capital Advisors, a merchant banking and financial consulting company, and CFO of Mission Solutions Group, a privately held defense sector firm. He earned an MBA from John Hopkins University and a BS in Mechanical Engineering from the University of Maryland. Mr. Boswell holds Series 24, 62, 63, 79, 82 and 99 licenses.

Recent News


Lexaria Bioscience Corp. (NASDAQ: LEXX)

The QualityStocks Daily Newsletter would like to spotlight Lexaria Bioscience Corp. (NASDAQ: LEXX).

Lexaria, a global innovator in drug delivery platforms, just announced ambitious plans for the 2024 calendar year

The letter confirms that the 2024 plans have been made possible by significant strides that were made by the company in 2023

Lexaria looks to build on the momentum gained from the previous year, ultimately asserting market dominance and making 2024 its best year yet

Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug delivery platforms, just announced its ambitious plans for the 2024 calendar year. In his annual letter, Chris Bunka, Lexaria's CEO, noted that this would mark the year that will prove all of the company's work of producing hard, factual scientific information worth it, accomplishments that were critical given 2023's challenges in the capital markets (

Lexaria Bioscience Corp. (NASDAQ: LEXX), a global innovator in drug delivery platforms, announced the final results from its completed human Pilot Study #1 that sought to evaluate the effectiveness of its patented DehydraTECH(TM) technology on the oral delivery of the glucagon-like peptide-1 ("GLP-1") drug semaglutide, available commercially in the branded product Rybelsus(R). "Most notable from its pilot study was the improved delivery of semaglutide to the bloodstream, which significantly improved blood sugar control. For one, in just 20 minutes after oral administration, the DehydraTECH-GLP-1 blood semaglutide level was about 261% higher than that of the control, a statistic that reflected the technology's ability to deliver drugs into the bloodstream faster. In addition, 24 hours after the ingestion of a single dose, the DehydraTECH GLP-1 blood semaglutide levels were approximately 44% higher than the control levels," a recent article reads. "The DehydraTECH-processed Rybelsus continued to reduce blood glucose even after eating. In addition, even as long as 24 hours after dose administration, Lexaria's DehydraTECH GLP-1 showed a 5.01% reduction in blood glucose level to baseline, an indicator of greater efficacy in achieving blood glucose reduction and helping attenuate the postprandial spikes in blood glucose experienced in the control group."

To view the full article, visit

Lexaria Bioscience Corp. (NASDAQ: LEXX) is a global innovator in drug delivery platforms. The company’s patented technology, DehydraTECH™, improves the way active pharmaceutical ingredients (APIs) enter the bloodstream by promoting healthier oral ingestion methods and increasing the effectiveness of fat-soluble active molecules. DehydraTECH promotes fast-acting, less expensive and more effective oral drug delivery and has been thoroughly evaluated through in vivo, in vitro and human clinical testing.

DehydraTECH is covered by 21 issued and more than 50 pending patents in over 40 countries around the world. Lexaria’s first patent was issued by the U.S. Patent and Trademark Office in October 2016 (US 9,474,725 B1), providing 20 years of patent protection expiring June 2034. Multiple patents have been awarded since then and are expected in the future.

Lexaria has also collaborated with the National Research Council (NRC), the Canadian government’s premier research and technology organization. The company has been granted patent protection for specific delivery of nicotine, vitamins, NSAIDs, antiviral drugs, cannabinoids and more.

Lexaria began developing DehydraTECH in 2014 and has since continued to strengthen and broaden the technology. The company has no plans to create or sell Lexaria-branded products containing controlled substances. Instead, Lexaria licenses its technology to other companies around the world to offer consumers the best possible performance across an array of ingestible product formats.

The company’s technology is best thought of as an additional layer that providers of consumer supplements, prescription and non-prescription drugs, nicotine and CBD products can utilize to improve the effectiveness of their own existing or planned new offerings. Lexaria has licensed DehydraTECH to multiple companies, including a world-leading tobacco producer for the research and development of smokeless, oral-based nicotine products, and for use in industries that produce cannabinoid beverages, edibles and oral products.

DehydraTECH is suitable for use with a wide range of product formats including pharmaceuticals, nutraceuticals, consumer packaged goods and over-the-counter capsules, pills, tablets and oral suspensions.

DehydraTECH Technology

Lexaria’s DehydraTECH is designed specifically for formulating and delivering lipophilic (fat-soluble) drugs and active ingredients. DehydraTECH increases their effectiveness and improves the way active pharmaceutical ingredients enter the bloodstream. The major benefits to a subject ingesting a DehydraTECH-enabled drug or consumer product can be summarized by the following:

  • Speeds up delivery – the effects of the product are felt by the subject in just minutes.
  • Increases bioavailability – the technology is much more effective at delivering a drug or product into the bloodstream.
  • Increases brain absorption – animal testing suggests significant improvement in the quantity of drug delivered across the blood-brain barrier.
  • Improves drug potency – more of the ingested product is made available to the body, so lower doses are required to achieve the desired effect.
  • Reduces drug administration cost – lower doses mean lower overall drug costs.
  • Masks unwanted taste – the technology eliminates or reduces the need for sweeteners.

Lexaria has demonstrated in animal studies a propensity for DehydraTECH technology to elevate the quantity of drug delivered across the blood-brain barrier by as much as 1,900 percent, initiating additional new patent applications and opening possibilities for improved drug delivery.

Since 2016, DehydraTECH has repeatedly demonstrated, with cannabinoids and nicotine, the ability to increase bio-absorption by up to five to 10 times, reduce time of onset from one to two hours to just minutes, and mask unwanted tastes. The technology is to be further evaluated for additional orally administered bioactive molecules, including antivirals, cannabinoids, vitamins, non-steroidal anti-inflammatory drugs (NSAIDs) and nicotine.

Market Outlook

Lexaria’s ongoing research and development efforts are mainly focused on development of product candidates across several key segments:

  • Oral Cannabinoids – a market estimated to be worth $18.4 billion in 2021 and expected to reach $46.2 billion by 2025.
  • Antivirals – an estimated $52.1 billion market in 2021 that’s expected to grow to $66.7 billion by 2025.
  • Oral Mucosal Nicotine – smokeless tobacco products, a $13.6 billion market in 2018, is forecast to grow at 7.2 percent annually through 2025.
  • Human Hormones – estrogen and testosterone replacement therapies represented a $21.9 billion market in 2019, with a forecast CAGR of 7.7 percent through 2027.
  • Ibuprofen and Naproxen – NSAID sales totaled $15.6 billion globally in 2019 and are projected to reach $24.4 billion by 2027.
  • Vitamin D3 – the global market size was $1.1 billion in 2021, growing at 7 percent per year and expected to reach $1.7 billion in 2026.

Management Team

Chris Bunka is Chairman and CEO of Lexaria Bioscience Corp. He is a serial entrepreneur who has been involved in several private and public companies since the late 1980s. He has extensive experience in the capital markets, corporate governance, mergers and acquisitions, as well as corporate finance. He is named as an inventor on multiple patent innovations.

John Docherty, M.Sc., is the President of Lexaria. He is a pharmacologist and toxicologist, and a specialist in the development of drug delivery technologies. He is the former president and COO of Helix BioPharma Corp. (TSX: HBP). He is named as an inventor on multiple issued and pending patents.

Greg Downey is Lexaria’s CFO. He has more than 35 years of diverse financial experience in the mining, oil and gas, manufacturing, and construction industries, and in the public sector. He served for eight years as CFO for several public companies and has provided business advisory and financial accounting services to many large organizations.

Gregg Smith is a strategic advisor to Lexaria. He is a founder and private investor with Evolution VC Partners. He is a member of the Sand Hill Angels and held previous investment banking roles with Cowen and Company and Bank of America Merrill Lynch.

Dr. Philip Ainslie serves as a scientific and medical advisor to Lexaria. He is co-director for the Centre for Heart, Lung and Vascular Health, Canada. He is also Research Chair in Cerebrovascular Physiology and Professor at the School of Health and Exercise Sciences, Faculty of Health and Social Development at the University of British Columbia.

Lexaria Bioscience Corp. (LEXX), closed Monday's trading session at $2.27, off by 1.3043%, on 204,199 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $0.6488/$3.5953.

Recent News

Eloro Resources Ltd. (TSX.V: ELO) (OTCQX: ELRRF)

The QualityStocks Daily Newsletter would like to spotlight Eloro Resources Ltd. (TSX.V: ELO) (OTCQX: ELRRF).

new report by the World Gold Council shows that in 2023, the demand for gold hit new highs as a slowdown in China's economy and geopolitical tensions drove investors to the precious metal. Last year, total gold transactions came to 4,899 tons, a slight increase from 2022's figure of 4,741. In December 2023, the price of gold stood at $2,100 per ounce as retail investors and central banks increased their gold purchases. The biggest drivers of the metal's demand were the Israel-Hamas conflict, the Russia-Ukraine war and China's weak economy. The global head of central banks at the World Gold Council, Shaokai Fan, believes that these factors will continue to boost gold's prices this year. In a recent interview, Fan stated that 2023 was the second-highest year in history of the central bank purchasing huge amounts of gold. For two consecutive years now, central bank gold purchases have exceeded 1,000 tons. Based on this year's outlook, the World Gold Council notes that the purchase of gold may not reach 2023 levels. However, it adds, a drop in inflation could prevent a significant drop in demand. In 2023, inflation in America stood at 3.3%, which is higher than the Fed's target of 2%. Last week, Federal Reserve chair Jerome Powell stated that it was unlikely interest rates would be cut next month. The great market conditions that gold is enjoying positions gold exploration companies such as Eloro Resources Ltd. (TSX: ELO) (OTCQX: ELRRF) well in terms of attracting investor interest.

Eloro Resources Ltd. (TSX.V: ELO) (OTCQX: ELRRF) is a publicly traded exploration and mine development company with a portfolio of gold and base-metal properties in Bolivia, Peru and Quebec.

The company has an option to acquire a 99% interest in the highly prospective Iska Iska Property, classified as a silver-tin polymetallic epithermal-porphyry complex, a significant mineral deposit type in the Potosi Department of southern Bolivia. Iska Iska is a road-accessible, royalty-free property.

Eloro also owns an 82% interest in the La Victoria Gold/Silver Project, located in the North-Central Mineral Belt of Peru, some 50 kilometers south of Barrick’s Lagunas Norte Gold Mine and Pan American Silver’s La Arena Gold Mine. La Victoria consists of eight mining concessions and eight mining claims encompassing approximately 89 square kilometers. La Victoria has good infrastructure, with access to road, water and electricity, and is located at an altitude that ranges from 3,150 meters to 4,400 meters above sea level.

The company has a strong management and technical team working diligently to uncover the value of both Iska Iska and La Victoria. Eloro is based in Toronto, Canada.


Iska Iska – Potosi, Bolivia

Iska Iska is associated with a Miocene possibly collapsed/resurgent caldera, emplaced on Ordovician age rocks with major breccia pipes, dacitic domes and hydrothermal breccias. The property is wholly controlled by the title holder, Empresa Minera Villegas S.R.L. It is located 48 kilometers north of Tupiza city, in the Sud Chichas Province of the Department of Potosi. This is an important mineral deposit type in the prolific South Mineral Belt of Bolivia. Eloro commissioned a NI 43-101 Technical Report on Iska Iska, which was completed by Micon International Limited and is available on Eloro’s website and under its filings on SEDAR.

A fully financed drill program is currently underway on the property, situated near world-class deposits including Silver Sand, San Bartolomé, Pulacayo, San Cristobal, San Vicente, Chorolque, Tasna, Choroma and Siete Suyos. Iska Iska is in the southwest part of the Eastern Cordillera, which hosts a number of major polymetallic mines and mineral deposits. Drilling and continuous channel sampling results have demonstrated some very high metal values, especially silver and tin, within an immense system, where mineralization has been encountered in every drill hole to date. The company believes there is excellent potential for world-class bulk mineable deposits.

La Victoria – Ancash, Peru

The La Victoria project, targeting gold and silver production, is situated near world-class, low-cost gold producers Pan American Silver and Barrick Gold Corporation. Located in Ancash Department, La Victoria sits on the western slopes of the Peruvian Andes. The property is located 12 hours from Lima, with a travel distance of 600 kilometers. The nearest road accessible population centers from La Victoria are Huandoval, Pallasca and Cabana. The project includes four principal mineralized zones in Peru’s prolific North-Central Mineral Belt – San Markito, Victoria, Victoria South and Ccori Orcco – with excellent potential for gold discovery. Operations at La Victoria are planned to proceed with a 2,000-meter diamond drilling program to test targets to outline potential resources at San Markito. Trenching and sampling confirmed high silver values and veins at San Markito in 2020.

Market Outlook

According to industry association The Silver Institute, the outlook for silver demand is exceptionally promising, with global demand forecast to rise to a record high of 1.112 billion ounces in 2022. The increase will be driven by record silver industrial fabrication, which is forecast to improve by 5%, as silver’s use expands primarily in solar energy and electric vehicle (EV) manufacturing. The institute states that government commitments to carbon neutrality have resulted in a rapid expansion of green energy projects, driving record photovoltaic panel installations which are expected to lift silver demand in this segment to an all-time high in 2022.

Rising demand in the electronics industry is also boosting the demand for tin, which is primarily used in solder. The electronics and electrical industries use solders containing 40-70% tin, which provide strong and reliable joints under a variety of environmental conditions. At present, the majority of the assemblers are using patented tin-and-copper-based solders. Mordor Intelligence estimated tin demand at 387 kilotons in 2021 and forecasts demand growth of 2.5% annually through 2027. Over the medium term, surging demand from the EV market and increasing applications in the electrical and electronics industry is expected to drive the market.

Management Team

Thomas G. Larsen is CEO of Eloro. He has more than 40 years of experience in the investment industry, specializing in corporate finance and management of junior resource companies, raising in excess of C$200 million. He previously held the position of President and Chief Executive Officer of Champion Iron Limited. Prior to that, he was President and Chief Executive Officer of Champion Iron Mines Limited.

Dr. Bill Pearson is Executive VP of Exploration for Eloro. He has more than 40 years of direct experience in the exploration and production of minerals worldwide. He played an integral role in the acquisitions of Desert Sun Mining Corp. by Yamana Gold in 2006 and Central Sun Mining by B2 Gold in 2009. He was formerly VP Exploration at Desert Sun Mining and Senior VP at Central Sun Mining.

Miles Nagamatsu, CPA, is CFO at Eloro. He has over 30 years of experience in accounting, management, lending, restructurings and turnarounds. Since 1993, he has acted as a CFO of public and private companies primarily in the mineral exploration and investment management sectors. He holds a Bachelor of Commerce degree from McMaster University.

Osvaldo Arce Burgoa is General Manager at Eloro. He is a geological and mineral processing engineer with 26 years of experience in Bolivia. He is a former President of the Bolivian Geological Society, Main Technical Advisor of the National Mining Corporation (COMIBOL) and has served as exploration manager and chief geologist at various mining and exploration companies. He has authored two books on Bolivian geology and holds a doctorate in mining engineering from Tohoku University in Sendai, Japan.

Eloro Resources Ltd. (OTCQX: ELRRF), closed Monday's trading session at $1.08, off by 1.6393%, on 15,903 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $1.026/$3.135.

Recent News

Clene Inc. (NASDAQ: CLNN)

The QualityStocks Daily Newsletter would like to spotlight Clene Inc. (NASDAQ: CLNN).

Researchers from ETH Zurich have developed a new magnetic resonance imaging (MRI) technique that can ease multiple sclerosis diagnosis and produce more accurate findings. Led by Emily Baadsvik and Markus Weiger from ETH Zurich's Institute for Biomedical Engineering, the research team created a technique to map myelin sheath conditions for more accurate diagnoses. Multiple sclerosis (MS) is a potentially disabling neurological condition that affects the central nervous system (brain and spinal cord). It occurs when the immune system becomes dysfunctional and starts to attack myelin, the protective sheath that covers and protects nerve fibers, resulting in communication problems between the rest of the body and the brain. The successful deployment of this new MRI technique in the field can increase the odds of successful treatment of MS patients when diagnosed early. The novel MS treatments from entities such as Clene Inc. (NASDAQ: CLNN) would be prescribed sooner when disease progression is still low.

Clene Inc. (NASDAQ: CLNN) is a late clinical-stage biopharmaceutical company focused on improving mitochondrial health and protecting neuronal function to treat neurodegenerative diseases, including amyotrophic lateral sclerosis (ALS), Parkinson’s disease, and multiple sclerosis (MS).

Its lead drug candidate is CNM-Au8®, an oral suspension developed to restore neuronal health and function by increasing energy production and utilization by driving critical cellular energy producing reactions that enable neuroprotection and remyelination to increase neuronal and glial resilience to disease-relevant stressors. CNM-Au8 is being studied in various clinical trials, including the Harvard/MGH Healey ALS Platform clinical trial for patients with ALS; RESCUE-ALS, a completed proof-of-concept clinical trial in patients with early symptomatic ALS; the REPAIR trials, completed target engagement clinical trials showing brain energy metabolite change with CNM-Au8; and a completed MS clinical trial for the treatment of visual pathway deficits in chronic optic neuropathy for remyelination in stable relapsing MS. The company also has a nanotherapeutic platform of drug discovery.


CNM-Au8, Clene’s lead asset, is a highly concentrated aqueous suspension of catalytically active, clean-surfaced, faceted gold nanocrystals. Multiple pathogenic insults contribute to neuronal death. Mitochondrial dysfunction and NAD+ decline is a common final pathway in neurodegeneration, with NAD+ as a critical determinant of cell survival and function. CNM-Au8’s catalytic mechanisms target the energetic deficits, oxidative stress and accumulation of misfolded proteins that are common to many neurodegenerative diseases.

The unique catalytic mechanism of action of CNM-Au8 is hypothesized to act as a neuroprotective and remyelinating therapy in neurodegenerative disease states in order to: (1) drive, support and maintain beneficial metabolic and energetic cellular reactions within diseased, stressed and/or damaged cells, (2) directly catalyze the reduction of harmful, reactive oxygen species (“ROS”) and (3) promote protein homeostasis via activation of the heat shock factor-1 pathway, recognized to dampen the cytotoxicity caused by misfolded and denatured proteins, which are known to occur ubiquitously in neurodegenerative diseases.

CNM-Au8 is used in combination with other agents, has no known drug-drug interactions, and is designed to improve function and survival. The clinical effects of both function and survival were seen in its clinical ALS trials, as earlier announced.

More than 500 estimated years of collective exposure across ALS, MS, and Parkinson’s disease participants in CNM-Au8 clinical trials and Expanded Access Protocol (compassionate use) programs have been recorded without any observed safety signals.

CNM-Au8 is a federally registered trademark of Clene Inc. Clene, based in Salt Lake City, Utah, with R&D and manufacturing operations in Maryland, began in 2013.

Market Opportunity

ALS is the most prevalent adult-onset progressive motor neuron disease, affecting approximately 30,000 people in the U.S. and an estimated 500,000 people worldwide, with a life expectancy of typically three to five years. Clene estimates that global ALS treatment sales will be greater than $1 billion annually within the coming few years. Additional treatments affecting daily function and survival remain the market need.

Additionally, there are more than 2 million MS patients globally, and Clene estimates the market size to be worth more than $23 billion annually. While the MS community has been successful at limiting relapses, non-relapsing MS patients continue to clinically deteriorate even while receiving effective immunomodulatory disease-modifying therapies (“DMTs”). A critical unmet medical need remains for therapeutic interventions that protect neuronal function and myelin health independent of immunomodulation to address progression independent of relapse activity.

Management Team

Robert Etherington is President, Director and CEO of Clene. He has more than 30 years of sales, marketing and leadership experience in the pharmaceutical industry. Prior to joining Clene, he worked at Actelion Pharmaceuticals, the largest biopharma company in the European Union prior to its acquisition by Johnson & Johnson in 2017, where he led that company’s U.S. commercial operations. He began his pharmaceutical sales and marketing career at Parke-Davis, a division of Pfizer, where he rose to the position of Team Leader overseeing the drug Lipitor.

Mark Mortenson is Chief Science Officer at Clene. He is co-inventor of the technology platform developed to produce the company’s therapeutics. He is the inventor or co-inventor on 32 other U.S. patents and hundreds of corresponding international patents. He is a former chief patent counsel responsible for 5,500 U.S. and international patents and patent applications. He holds bachelor’s degrees in physics and ceramic engineering from Alfred University, a master’s degree in materials science from Penn State University and a J.D. from George Washington University.

Benjamin Greenberg, M.D., MHS, FAAN, is Head of Medical at Clene. He is an internationally recognized expert in disorders of the central nervous system. He is currently professor of neurology and Vice Chair of Clinical and Translational Research in the department of Neurology at University of Texas Southwestern Medical Center in Dallas. He holds a bachelor’s degree from Johns Hopkins, a master’s degree in molecular microbiology and immunology from the Johns Hopkins School of Public Health and graduated from Baylor College of Medicine. He served residency in neurology at The Johns Hopkins Hospital.

Morgan R. Brown is CFO at Clene. He has more than 30 years of finance and accounting experience, with 23 years at biotech, pharmaceutical and medical device companies. He has served in similar roles at Lipocine Inc., Innovus Pharmaceuticals, World Heart Corp., Lifetree Clinical Research and NPS Pharmaceuticals Inc. He previously worked at accounting firm KPMG. He is a CPA with a bachelor’s degree in accounting from Utah State University and an M.S. in business administration from the University of Utah.

Clene Inc. (NASDAQ: CLNN), closed Monday's trading session at $0.42, off by 1.2462%, on 278,797 volume. The average volume for the last 3 months is 933,286 and the stock's 52-week low/high is $0.25/$1.99.

Recent News

Prospera Energy Inc. (TSX.V: PEI) (FRA: OF6B) (OTC: GXRFF)

The QualityStocks Daily Newsletter would like to spotlight Prospera Energy Inc. (TSX.V: PEI) (OTC: GXRFF) .

With major companies such as McDonald's Corporation and Walmart Stores naming sustainability as one of their top priorities in recent years, many companies are facing pressure to ensure they incorporate sustainability into their goods and service delivery. However, one of the main criticisms against corporate sustainability in the past few years has been that it contradicts the fiduciary duty of managers by not putting company shareholders first. Corporate sustainability refers to a business approach that involves pursuing social and economic strategies to create sustainable value for shareholders, company employees, consumers and societal value.A 2016 paper titled "Corporate Sustainability: First Evidence on Materiality" challenged this notion by outlining financially material environmental, social and governance ("ESG") factors that could help improve portfolio returns. The paper noted that sustainability practices are in line with activities that create shareholder value. For companies that aren't fully sold on the bottom-line benefits of implementing ESG best practices, a number of examples such as Prospera Energy Inc. (TSX.V: PEI) (OTC: GXRFF) (FRA: OF6B) are showing that it can be done.

Prospera Energy Inc. (TSX.V: PEI) (OTC: GXRFF) (FRA: OF6B) is a public oil and gas exploration, exploitation and development company focusing on conventional oil and gas reservoirs in Western Canada. The company uses its experience to develop, acquire and drill assets with potential for primary and secondary recovery.

Prospera is primarily focused on optimizing hydrocarbon recovery from legacy fields through environmentally safe and efficient reservoir development methods and production practices. It is in the midst of a three-stage restructuring process aimed at prioritizing cost effective operations while appreciating production capacity and reducing liabilities.

The company is based in Calgary, Alberta, Canada.


Prospera’s core properties include more than 42,000 cumulative acres across Cuthbert, Luseland and Heart Hills in Saskatchewan and Red Earth and Pouce Coupe in Alberta. In total, the company estimates that there are half a billion barrels of oil in place at these sites accounting for 20+ years of forward project lifespan, with as little as 8% of total reserves having been recovered via legacy vertical well technology.

Restructuring Initiative

In 2021, Prospera enacted a top-down reorganization. The early results of these efforts were on display in May 2023, when the company reported a three-fold year-over-year increase in annual revenue for 2022 alongside drastically reduced operating costs and record-high cash flow from operations.

Prospera noted in the news release that it has positioned itself in 2023 to execute the second phase of its development plan aimed at increasing production through medium-oil development in Alberta and leveraging horizontal wells to capture the significant remaining reserves in Saskatchewan.

During the company’s investor summit in August 2023, Prospera CEO Samuel David provided more information regarding this three-phase strategy:

Phase I

Prospera completed the first phase of its restructuring by optimizing operations at its existing assets and addressing legacy arrears and non-compliance issues.

At the beginning of this transformation, the company was producing just 80 barrels of oil equivalent (BOE) per day. In Q4 of last year, Prospera peaked at nearly 1,200 BOE per day. Its breakeven is around 500 barrels per day, illustrating the opportunity for free cash flow. This prospect has driven Prospera’s capital development and optimization in recent quarters.

After a temporary slowdown in production due to harsh winter conditions, Prospera is currently producing about 800 BOE per day and anticipates an additional 300-500 barrels of daily production following the completion of ongoing site maintenance work.

This sustained increase has pushed the company’s NPV from roughly $3 million prior to the restructuring efforts to approximately $72 million today.

In an effort to build on this progress and maximize its available resources, Prospera piloted two horizontal reentries to assess a potential horizontal well transformation at its properties.

Phase II

Following up on the optimization efforts of Phase I, Prospera aims to commence a horizontal well transformation at its properties in the coming months. Based on its pilot wells from Phase I, the company has proposed 10 horizontal well locations at its Cuthbert and Heart Hills properties.

Prospera has likewise proposed eight medium light oil direction wells at its Alberta property, and it is exploring strategic acquisitions aimed at expanding its core area and diversifying its product mix.

Other facets of Phase II include piloting an enhanced oil recovery (EOR) application and continuing to execute its liability management goals and ESG initiatives. Prospera has already abandoned 60 vertical wells as part of its three-year LMR plan to reclaim surface land and reduce the environmental footprint of its operations.

Phase III

Beginning next year, Phase III of Prospera’s corporate redevelopment strategy will focus on continuing the company’s horizontal modular development to appreciate production and optimize recovery of remaining reserves. Prospera intends to implement full-scale EOR applications based on the results of its Phase II pilot program, which is forecast to optimize recovery by greater than 10%.

Prospera also intends to continue its acquisition strategy to diversify its product mix. Its goal, as detailed by in August 2023 investor summit, is to attain 50% light oil, 40% heavy oil and 10% gas – all while continuing to eliminate carbon emissions as part of its existing ESG initiatives.

Poised for Growth

Following its transformational efforts in 2022, Prospera is poised to achieve record growth in 2023. The company has forecast significant reductions in production costs through 2024, alongside sizable increases in daily production.

Prospera is currently exploring strategic acquisition targets to potentially increase its production beyond 5,000 BPD while expanding its reserve base to a billion barrels.

Market Opportunity

While the oil and gas industry faces long-term geopolitical and macroeconomic uncertainty, there is a clear trend to secure supply in the short term. According to Deloitte, the global upstream industry ended 2022 with some of the highest free cash flows on record, driving reinvestment in hydrocarbons and overall investment in clean energy.

The Energy Information Administration recently forecast a dip in global oil inventories over each of the next five quarters, placing upward pressure on oil prices. The agency further forecasts a YoY increase in fuel consumption, exacerbating the effects of OPEC+ production cuts that are set to remain in place through 2024.

For Prospera, these forecasts are promising. The company aims to build on its recent financial growth in the coming months (Prospera reported a three-fold YoY increase in revenue to $13.9 million in 2022), hitting a projected $57 million in total revenue by the end of 2024 while working to expand its core area holdings through accretive M&A transactions.

Leadership Team

Prospera is led by a team with extensive, diverse petroleum industry experience spanning both reservoir management and operations of oil and gas assets. The team boasts a proven track record of reorganizing companies, structuring financing arrangements and positioning for growth.

Samuel David is the company’s President and CEO. He brings to Prospera over 32 years of experience in operation, development and management of oil and gas assets and companies. Mr. David holds a B.Sc. in Mechanical Engineering and a B.A. in Economics from the University of Calgary. His background consists of both engineering and executive management experience with majors Petro-Canada, AEC Oil & Gas (now EnCana / Cenovus) and Husky Energy, as well as founding and operating juniors Ventura Energy and First West Petroleum. Mr. David has proven expertise in corporate planning, production, reservoir engineering, depletion strategies, EOR, property evaluations, acquisitions and divestitures.

George Magarian is VP Subsurface for Prospera. He is a professional petroleum geologist (APEGA) with over 36 years’ experience in the Western Canada Sedimentary Basin. After graduating with an Honors B.Sc. degree in Earth Science from the University of Waterloo, Mr. Magarian spearheaded many successful exploration programs, conducted evaluations for improved recovery schemes and assessed/exploited unconventional oil reservoir opportunities. He has held roles of increasing responsibility, from exploration geologist at oil industry major Petro-Canada and intermediates Anderson Exploration and Jordan Petroleum, to geoscience manager and VP exploration at junior companies Ionic Energy, Gentry Resources and Westfire Energy.

Chris Ludtke is the company’s VP Finance & Accounting. He is a high functioning finance leader with extensive expertise in finance, budgets and planning, accounting, economic evaluation, management, governance and sound decision making. Mr. Ludtke has 20 years of experience within the oil and gas, clean energy and renewables industries, including 12+ years working for Husky Energy before moving into an executive role in the junior oil and gas and hydrogen space. He graduated from the University of Lethbridge (Bachelor of Management) and is a Chartered Professional Accountant in the Province of Alberta.

Matthew Kenna is the CFO of Prospera. He has over 30 years’ experience leading organizations and helping them expand, drive efficiencies and grow profitability. Mr. Kenna is a professional accountant (CPA, CMA) and spent 15 years heading up the financial and operating departments at KUDU Industries, where he fostered financing arrangements, client relationships and manufacturing teams to take the organization from $35M to $150M in revenue. He has extensive experience turning companies around, growing them and building efficient organizations.

Prospera Energy Inc. (OTC: GXRFF), closed Monday's trading session at $0.0572, off by 4.0268%, on 276,225 volume. The average volume for the last 3 months is 148,452 and the stock's 52-week low/high is $0.0485/$0.134.

Recent News

Software Effective Solutions Corp. (OTC: SFWJ)

The QualityStocks Daily Newsletter would like to spotlight Software Effective Solutions Corp. (OTC: SFWJ).

Software Effective Solutions (OTC: SFWJ) is among companies in the cannabis space paying close attention to the mounting calls for the rescheduling of cannabis to a Schedule III from a Schedule I substance per the Controlled Substances Act ("CSA"). "The call for cannabis rescheduling on the CSA list is not new, but it has gained momentum since the U.S. Department of Health and Human Services (‘HHS') sent a brief letter to the head of the U.S. Drug Enforcement Administration… ‘HHS is believed to have advised DEA to move marijuana from Schedule I to Schedule III of the Controlled Substances Act ("CSA"), and the law enforcement agency is now carrying out its own review before making a final determination,'" reads a recent article, which contains excerpts from an report in Marijuana Moment. "A change in the rescheduling would almost certainly benefit Software Effective Solutions, a global infrastructure and holding company in the cannabis industry. Operating as MedCana, the company currently has five divisions focused on pharmaceutical cannabis production, as well as a software company focused on managing processes for plant-to-patient operations. The recent acquisition of an irrigation and greenhouse technology company has rounded out MedCana's portfolio of holdings… The company is committed to building technology, laboratories, growing facilities, and scientific teams needed to provide pharmaceutical-grade cannabis extracts to the world."

To view the full article, visit

Software Effective Solutions Corp. (d/b/a MedCana) (OTC: SFWJ) is a global infrastructure and holding company in the cannabis industry. MedCana currently has five companies focused on pharmaceutical cannabis production, as well a software company focused on managing processes for plant-to-patient operations. The recent acquisition of an irrigation and greenhouse technology company has rounded out MedCana’s portfolio of holdings.

MedCana’s focus is on developing clients and companies in Latin America, initially in Colombia, and partnerships with laboratories, research facilities and hospitals throughout the world. MedCana is building the technology, laboratories, growing facilities and scientific teams to provide premium pharmaceutical-grade cannabis extracts to the world.

MedCana’s goal is to be the world’s premier resource for pharmaceutical cannabis products. The company believes its advantage is its global view and reach. From initial cultivation to final product, MedCana aims to help partners produce pharmaceutical CBD and other extracts that will have no equal.

The company’s mission is to utilize its technology to partner with and develop companies that provide premium pharmaceutical-grade cannabis extracts with absolute integrity, sustainability and social responsibility. MedCana’s team of pharmaceutical scientists includes some of the most respected chemists in the world. They aim to ensure that the company’s customers and partners create premium cannabis extracts that meet the growing worldwide demand. MedCana’s software is designed to ensure traceability and quality from seed to finished product.

MedCana is headquartered in Austin, Texas, with offices in Colombia.


MedCana announced in May 2023 the beginning of full-scale production of non-THC cannabis for export to Europe in response to high demand in that market. This expansion comes after the successful completion of full crop cycle testing and infrastructure development at production sites in Columbia.

The recent acquisition of the assets of Tokan Corp., a software company focused on creating an enterprise resource planning (ERP) platform for the cannabis industry, and Eko2O S.A.S., a greenhouse and irrigation engineering company, has positioned MedCana for explosive growth in the region.

As a MedCana subsidiary, Eko2O SA will increase the company’s revenue potential in Central and South America. The subsidiary specializes in the construction and distribution of greenhouses and sophisticated irrigation platforms. A positive outlook has resulted from the company’s expansion as it investigates new opportunities for greenhouse and irrigation system installations in Panama and Uruguay. These opportunities are expected to accelerate Eko2O’s development and strengthen its position as a top supplier of innovative agricultural solutions in cannabis and other sectors that are quickly moving to high technology agricultural production.

In addition, MedCana has started talks with the government in Argentina about possible incentives for beginning operations in that country as part of its ongoing worldwide development strategy. Support from the Argentinean government and the start of new operations there would greatly increase MedCana’s market share in Latin America and solidify the company’s position as the market leader in the cannabis industry.

Market Opportunity

According to a report by Grand View Research, a San Francisco-based market research and consulting company, the global cannabis extract market was valued at $3.5 billion in 2022 and is expected to expand at a CAGR of 20% from 2023 to 2030 to be worth more than $15 billion.

Growing demand for cannabis extracts, including oils and tinctures, and the increased legalization of marijuana for the treatment of different chronic ailments like arthritis, Alzheimer’s, anxiety and cancer are driving the expansion of the industry. The marijuana derivative industry is flourishing due to a greater understanding of its various medical benefits.

Management Team

Jose Gabriel Diaz is CEO of MedCana. He has successfully built, grown and sold multiple telecom companies. He was senior vice president of sales at IP Communications, a national high-speed data provider. He also founded Reallinx, a national data carrier later sold to GTT Communications. Additionally, he is currently president of the A.E.M. Business and Entrepreneurship Association in Austin, Texas.

Claudio Jiménez Cartagena, QF, Ph.D. is Chief Scientific Officer at MedCana. He joined MedCana after working with Sosteli Pharma as Technical Director and serving as a director consultant for the Corporation for Agricultural Industrial Development at the University of Antioquia in Colombia. Before that, he worked as the scientific director at the Institute of Food Science & Technology. He holds a bachelor’s degree in pharmaceutical chemistry, a master’s degree in basic biomedical sciences and a doctoral degree in Environmental Engineering from the University of Antioquia.

Julián Alberto Londoño Londoño, Ph.D., is Senior Vice President of Operations at MedCana. He previously served as general manager for the Corporation for Agricultural Industrial Development, and as Chief Scientific Officer at Sosteli Pharma in the Resource Management Department. He has developed multiple U.S. patents, and recently served as senior advisor to the Secretariat of Agriculture Development for the Government of Antioquia. He holds a doctorate in Chemical Sciences from the University of Antioquia.

Software Effective Solutions Corp. (OTC: SFWJ), closed Monday's trading session at $0.0539, even for the day. The average volume for the last 3 months is 2,062 and the stock's 52-week low/high is $0.000001/$0.09.

Recent News

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers

The QualityStocks Sponsored News

The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal

The QualityStocks Sponsored News

The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal

The QualityStocks Sponsored News

The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.